PMID,Title
25999454,Inherited genetic variation in childhood acute lymphoblastic leukemia.
23640184,Challenges in pharmacogenetics.
18466097,"Serotonin type 3 receptor genes: HTR3A, B, C, D, E."
24474498,VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in children.
26710337,A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial Fibrillation.
19924111,"Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment."
23859574,Pharmacodynamic genetic variants related to antipsychotic adverse reactions in healthy volunteers.
12065557,Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes.
19259653,CYP2C19 genotype is associated with symptomatic recurrence of GERD during maintenance therapy with low-dose lansoprazole.
21521023,Variability in transport and biotransformation of cytarabine is associated with its toxicity in peripheral blood mononuclear cells.
18174457,"Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy."
21546862,PharmGKB summary:  citalopram pharmacokinetics pathway.
11543734,Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression.
18285551,Association of common C-reactive protein (CRP) gene polymorphisms with baseline plasma CRP levels and fenofibrate response: the GOLDN study.
19179847,Genetics of dopamine receptors and drug addiction: a comprehensive review.
17955230,CYP2C9 genotypes and the quality of anticoagulation control with warfarin therapy among Brazilian patients.
26129906,Genetics-Based Population Pharmacokinetics and Pharmacodynamics of Risperidone in a Psychiatric Cohort.
25897911,CYP2C19 LOF alleles confer no risk for HTPR but higher risk for recurrent ischemic events in clopidogrel treated elderly ACS patients.
20807074,Disinhibition as a side effect of treatment with fluvoxamine in pediatric patients with obsessive-compulsive disorder.
20130494,Association of common variants of CYP4A11 and CYP4F2 with stroke in the Han Chinese population.
19825907,Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism.
24140730,Relationship between statin type and responsiveness to clopidogrel in patients treated with percutaneous coronary intervention: a subgroup analysis of the CILON-T trial.
23835420,Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration.
23080225,Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants.
25461249,PPARA gene and phenprocoumon: a new predictor of response variability.
18794729,Polymorphism of the hepatic influx transporter organic anion transporting polypeptide 1B1 is associated with increased cholesterol synthesis rate.
21625751,Association study between genetic monoaminergic polymorphisms and OCD response to clomipramine treatment.
23556448,Association of a functional FAAH polymorphism with methamphetamine-induced symptoms and dependence in a Malaysian population.
23682072,Characterization of raloxifene glucuronidation: potential role of UGT1A8 genotype on raloxifene metabolism in vivo.
10668847,Increased bioavailability of oral melatonin after fluvoxamine coadministration.
29737521,Age- and Genotype-Dependent Variability in the Protein Abundance and Activity of Six Major Uridine Diphosphate-Glucuronosyltransferases in Human Liver.
23973251,SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.
27549341,Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer.
23646118,Effects of CYP2C19 loss-of-function variants on the eradication of H. pylori infection in patients treated with proton pump inhibitor-based triple therapy regimens: a meta-analysis of randomized clinical trials.
23989394,Cyanosis in a male Nigerian infant with acute kidney injury: answers.
18618621,SLC6A4 variation and citalopram response.
26265231,Genetic and platelet function testing of antiplatelet therapy for percutaneous coronary intervention: the ARCTIC-GENE study.
24080498,Pharmacogenetic associations with plasma efavirenz concentrations and clinical correlates in a retrospective cohort of Ghanaian HIV-infected patients.
8861656,Use of electrospray ionization liquid chromatography-mass spectrometry to study the role of CYP2D6 in the in vitro metabolism of 5-hydroxytryptamine receptor antagonists.
25163792,Population pharmacogenetic pharmacokinetic modeling for flip-flop phenomenon of enteric-coated mycophenolate sodium in kidney transplant recipients.
22954510,Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol.
24353446,"Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel response."
21412232,Pharmacogenetics: from bench to byte--an update of guidelines.
23609393,Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.
5365949,An improved and simplified method of detecting the acetylator phenotype.
12414349,Pharmacogenetics of acenocoumarol: cytochrome P450 CYP2C9 polymorphisms influence dose requirements and stability of anticoagulation.
14652703,Increased incidence of CYP2D6 gene duplication in patients with persistent mood disorders: ultrarapid metabolism of antidepressants as a cause of nonresponse. A pilot study.
19890253,Transporter pharmacogenetics and statin toxicity.
19183167,Additive role of tiotropium in severe asthmatics and Arg16Gly in ADRB2 as a potential marker to predict response.
27225724,Effects of Genetic Polymorphism in CYP3A4 and CYP3A5 Genes on Tacrolimus Dose Among Kidney Transplant Recipients.
12623934,ACE and alpha-adducin polymorphism as markers of individual response to diuretic therapy.
8857546,Individualizing therapy with 6-mercaptopurine and 6-thioguanine related to the thiopurine methyltransferase genetic polymorphism.
10523341,The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study.
16302021,Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder.
26846104,DPYD gene polymorphisms are associated with risk and chemotherapy prognosis in pediatric patients with acute lymphoblastic leukemia.
17431185,Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.
12844134,Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.
19057513,Renin-angiotensin system and alpha-adducin gene polymorphisms and their relation to responses to antihypertensive drugs: results from the GENRES study.
21810746,Genome-wide association study identifies variations in 6p21.3 associated with nevirapine-induced rash.
24101478,Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity.
26441325,ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection.
24362944,"Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C."
26153084,CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy.
23797529,The role of CYP2C8 genotypes in dose requirement  and levels of everolimus after heart transplantation.
15564883,Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients.
17192506,Effect of polymorphic CYP3A5 genotype on the single-dose simvastatin pharmacokinetics in healthy subjects.
19106084,Cytochrome p-450 polymorphisms and response to clopidogrel.
26977927,A New Pharmacogenetic Algorithm to Predict the Most Appropriate Dosage of Acenocoumarol for Stable Anticoagulation in a Mixed Spanish Population.
21996196,Lymphocyte counts in kidney allograft recipients are associated with IMPDH2 3757T&amp;gt;C gene polymorphism.
27574448,Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel.
19626000,"Clozapine, GABA(B), and the treatment of resistant schizophrenia."
16786511,"Genetic variability, haplotypes, and htSNPs for exons 1 at the human UGT1A locus."
20801498,Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial.
21614492,A candidate gene study of serotonergic pathway genes and pain relief during treatment with escitalopram in patients with neuropathic pain shows significant association to serotonin receptor2C (HTR2C).
16418702,Heterozygous mutation in CYP2C19 significantly increases the concentration/dose ratio of racemic citalopram and escitalopram (S-citalopram).
18834373,Influence of CYP2D6*10 on the pharmacokinetics of metoprolol in healthy Korean volunteers.
21502584,Pharmacogenomics: the genetics of variable drug responses.
18574025,The largest prospective warfarin-treated cohort supports genetic forecasting.
28624888,"Steady-state pharmacokinetics of mycophenolic acid in renal transplant patients: exploratory analysis of the effects of cyclosporine, recipients' and donors' ABCC2 gene variants, and their interactions."
15963082,Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status.
15213846,The risk of bleeding complications in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon.
18538445,Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patients.
22547143,Added value of pharmacogenetic testing in predicting statin response: results from the REGRESS trial.
26421491,Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
14573314,Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment.
24656015,Influence of cytochrome P450 3A5 polymorphisms on viral infection incidence in kidney transplant patients treated with tacrolimus.
21047201,Nucleotide excision repair gene polymorphisms may predict acute toxicity in patients treated with chemoradiotherapy for bladder cancer.
26307985,Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation.
16945988,"Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1/*1 genotype."
23942138,SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalink.
21075428,The cytochrome 2C19*2 and *3 alleles attenuate response to clopidogrel similarly in East Asian patients undergoing elective percutaneous coronary intervention.
16201835,A C1173T dimorphism in the VKORC1 gene determines coumarin sensitivity and bleeding risk.
20584552,"The role of clinical variables, neuropsychological performance and SLC6A4 and COMT gene polymorphisms on the prediction of early response to fluoxetine in major depressive disorder."
27217270,Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.
25950242,Subjective response as a consideration in the pharmacogenetics of alcoholism treatment.
20350125,"Pharmacogenomics of membrane transporters: past, present and future."
26033222,Rasburicase-induced methaemoglobinaemia and G6PD deficiency in an unusual suspect.
15520364,Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
19057464,Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.
19801958,Association of IL-1B genetic polymorphisms with an increased risk of opioid and alcohol dependence.
21878834,Mycophenolic acid-related diarrhea is not associated with polymorphisms in SLCO1B nor with ABCB1 in renal transplant recipients.
26313268,"Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer."
16495778,Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz.
18281305,Impact of CYP2B6 983T&amp;gt;C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients.
22882994,Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes.
19238167,Functional analysis of a mutation in the SLCO1B1 gene (c.1628T&amp;gt;G) identified in a Japanese patient with pravastatin-induced myopathy.
28139840,Novel Genetic Variants in Carboxylesterase 1 Predict Severe Early-Onset Capecitabine-Related Toxicity.
23394389,Characterization of the CYP2D6 gene locus and metabolic activity in Indo- and Afro-Trinidadians: discovery of novel allelic variants.
15614026,Single nucleotide polymorphisms predict the change in left ventricular mass in response to antihypertensive treatment.
15710002,Concomitant dosing of famotidine with a triple therapy increases the cure rates of Helicobacter pylori infections in patients with the homozygous extensive metabolizer genotype of CYP2C19.
18690342,An analysis of the relative effects of VKORC1 and CYP2C9 variants on anticoagulation related outcomes in warfarin-treated patients.
29333880,Pharmacogenetic analysis of opioid dependence treatment dose and dropout rate.
14998425,CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes.
25950190,Eradication of T315I mutation in chronic myeloid leukemia without third-generation tyrosine kinase inhibitor: a case report.
20029385,Weight gain related to treatment with atypical antipsychotics is due to activation of PKC-β.
12610741,CYP2D6*10 alleles do not determine plasma fluvoxamine concentration/dose ratio in Japanese subjects.
17018806,Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
22759796,The dual role of pharmacogenetics in HIV treatment: mutations and polymorphisms regulating antiretroviral drug resistance and disposition.
18687376,Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment.
18322281,Genetic determinants of response to warfarin during initial anticoagulation.
24723432,Lack of influence of DAT1 and DRD2 gene variants on antidepressant response in generalized anxiety disorder.
20452521,Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.
21037509,Variants of ADAMTS1 modify the effectiveness of statins in reducing the risk of myocardial infarction.
27507617,Genotype-Guided Dosing Study of FOLFIRI plus Bevacizumab in Patients with Metastatic Colorectal Cancer.
18444945,Association of four DNA polymorphisms with acute rejection after kidney transplantation.
26739304,High Resectability Rate of Initially Unresectable Colorectal Liver Metastases After UGT1A1-Adapted High-Dose Irinotecan Combined with LV5FU2 and Cetuximab: A Multicenter Phase II Study (ERBIFORT).
22885912,Serotonin transporter genotype and function in relation to antidepressant response in Koreans.
26977146,The Impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 Polymorphisms on Metformin Therapeutic Efficacy in Chinese Type 2 Diabetes Patients.
16321621,"The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment."
30366777,Functional characterization of 50 CYP2D6 allelic variants by assessing primaquine 5-hydroxylation.
20215968,KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study.
26894651,A candidate gene approach of the calcineurin pathway to identify variants associated with clinical outcomes in renal transplantation.
20118554,Effects of cigarette smoking and cytochrome P450 2D6 genotype on fluvoxamine concentration in plasma of Japanese patients.
17853254,Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder.
21270786,CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.
27714501,"IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C."
22566560,Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain.
15350163,Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
8013282,"The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron."
24725652,Methylenetetrahydrofolate reductase gene variants and antipsychotic-induced weight gain and metabolic disturbances.
26164721,"Individual and Combined Associations of Genetic Variants in CYP3A4, CYP3A5, and SLCO1B1 With Simvastatin and Simvastatin Acid Plasma Concentrations."
9149697,Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension.
17914325,Pharmacogenetics in modern psychiatry.
15739035,"BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial."
23279643,The VKORC1 and CYP2C9 genotypes are associated with over-anticoagulation during initiation of warfarin therapy in children.
25115783,Methaemoglobinaemia in a G6PD-deficient child treated with rasburicase.
23993903,PON1 Q192R genotype influences clopidogrel responsiveness by relative platelet inhibition instead of on-treatment platelet reactivity.
22960765,Inosine monophosphate dehydrogenase polymorphisms and renal allograft outcome.
25155933,Familial risk for alcohol dependence and developmental changes in BMI: the moderating influence of addiction and obesity genes.
22304582,Pharmacogenomics of the heptahelical receptor regulators G-protein-coupled receptor kinases and arrestins: the known and the unknown.
28745549,Prior opioid exposure influences parents' sharing of their children's CYP2D6 research results.
21174626,Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics.
8946471,A new CYP2D6 allele with a nine base insertion in exon 9 in a Japanese population associated with poor metabolizer phenotype.
18241283,Effect of CYP2C19*2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians.
26632884,A novel polymorphism near HLA class II region is associated with spontaneous clearance of HCV and response to interferon treatment in Chinese patients.
18784654,Genetic variation in the CYP2D6 gene is associated with a lower heart rate and blood pressure in beta-blocker users.
25461247,Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.
22573495,Methemoglobinemia and hemolysis in a patient with G6PD deficiency treated with rasburicase.
22026923,Additive effect of GHRd3 and COLIA1 polymorphisms on the GH-substitution dose in GH-deficient adults.
26264253,Predictive factors for 24 weeks sustained virologic response (SVR24) and viral relapse in patients treated with simeprevir plus peginterferon and ribavirin.
26877068,Race-Specific Influence of CYP4F2 on Dose and Risk of Hemorrhage Among Warfarin Users.
2340091,"Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression."
22293536,PharmGKB summary:  caffeine pathway.
24590773,Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial.
18797858,"Identification of a novel non-functional CYP2D6 allele, CYP2D6*69, in a Caucasian poor metabolizer individual."
18330458,Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients.
27439447,Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients.
23150151,"Effect of the CYP2C19 2 and 3 genotypes, ABCB1 C3435T and PON1 Q192R alleles on the pharmacodynamics and adverse clinical events of clopidogrel in Chinese people after percutaneous coronary intervention."
11027924,Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression.
20679962,Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil.
26615671,Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase.
26536870,Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover.
27548009,Association between DCK 35708 T&amp;gt;C variation and clinical outcomes of acute myeloid leukemia in South Chinese patients.
18398146,Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer.
9689128,Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.
27780742,Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis.
11926893,Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy.
25329996,Effects of cytochrome P450 2C19 and paraoxonase 1 polymorphisms on antiplatelet response to clopidogrel therapy in patients with coronary artery disease.
10673478,The pharmacological properties of tiotropium.
18222353,Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials.
23588314,"CYP3A5 genotype, but not CYP3A4*1b, CYP3A4*22, or hematocrit, predicts tacrolimus dose requirements in Brazilian renal transplant patients."
15703762,The genetics of human obesity.
19530961,Impact of apolipoprotein A5 variants on statin treatment efficacy.
27247849,Genetic variation and cognitive dysfunction in opioid-treated patients with cancer.
17289397,"Tolerability of statins is not linked to CYP450 polymorphisms, but reduced CYP2D6 metabolism improves cholesteraemic response to simvastatin and fluvastatin."
24019752,CYP2C19 polymorphisms in the Thai population and the clinical response to clopidogrel in patients with atherothrombotic-risk factors.
12955294,"The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder."
17726453,"Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia."
15467211,Nonlinear mixed effects model analysis of the pharmacokinetics of metoprolol in routinely treated Japanese patients.
17697394,Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea.
23920449,MC4R rs489693: a clinical risk factor for second generation antipsychotic-related weight gain?
23930676,Genetic variation in the PPARA gene is associated with simvastatin-mediated cholesterol reduction in the Rotterdam Study.
22927450,A single-nucleotide polymorphism in CYP2B6 leads to &amp;gt;3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women.
28002639,Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron.
9369411,Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies.
20235793,Pharmacogenetic influences on mycophenolate therapy.
25000516,NT5C3 polymorphisms and outcome of first induction chemotherapy in acute myeloid leukemia.
24415675,The association between fasting hypoglycemia and methylated mercaptopurine metabolites in children with acute lymphoblastic leukemia.
24220207,PharmGKB summary: mycophenolic acid pathway.
25751398,"Hypothalamic-pituitary-adrenal system, neurotrophic factors and clozapine response: association with FKBP5 and NTRK2 genes."
10507506,"Human cytochromes and some newer antidepressants: kinetics, metabolism, and drug interactions."
16874005,"Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients."
25877345,CYP2C19 polymorphism and clinical outcomes among patients of different races treated with clopidogrel: A systematic review and meta-analysis.
18838503,"Expression and functional analysis of CYP2D6.24, CYP2D6.26, CYP2D6.27, and CYP2D7 isozymes."
23274376,Cisplatin-induced ototoxicity in pediatric solid tumors: the role of glutathione S-transferases and megalin genetic polymorphisms.
21449676,Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample.
15280927,UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer.
19770842,An inosine 5'-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid.
7202824,"Effects of age, cigarette smoking and the oral contraceptive on the pharmacokinetics of clomipramine and its desmethyl metabolite during chronic dosing."
17439540,SLCO1B1 521T--&amp;gt;C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patients.
23809542,The CYP2C19*17 variant is not independently associated with clopidogrel response.
25155931,Rescue morphine in mechanically ventilated newborns associated with combined OPRM1 and COMT genotype.
18668430,Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family.
18261733,"Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER."
25844821,Lansoprazole Is Associated with Worsening Asthma Control in Children with the CYP2C19 Poor Metabolizer Phenotype.
19005277,Increase in serum bilirubin in HIV/hepatitis-C virus-coinfected patients on atazanavir therapy following initiation of pegylated-interferon and ribavirin.
23856854,Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders.
21121774,CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine.
20031551,Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response.
23209099,Lethal effect of a single dose of rasburicase in a preterm newborn infant.
21386754,"Cerivastatin, genetic variants, and the risk of rhabdomyolysis."
20127091,Ciprofloxacin-induced acute haemolytic anaemia in a patient with glucose-6-phosphate dehydrogenase Mediterranean deficiency: a case report.
24729586,Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes.
16270629,VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation.
19671875,Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.
1451721,Steady-state plasma levels of clomipramine and its metabolites: impact of the sparteine/debrisoquine oxidation polymorphism. Danish University Antidepressant Group.
22094953,Associations of ABCB1 3435C&amp;gt;T and IL-10-1082G&amp;gt;A polymorphisms with long-term sirolimus dose requirements in renal transplant patients.
17587760,Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia.
23860572,Rasburicase causing severe oxidative hemolysis and methemoglobinemia in a patient with previously unrecognized glucose-6-phosphate dehydrogenase deficiency.
16580900,Environmental and genetic factors associated with morphine response in the postoperative period.
21332315,"Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse."
21684175,"alcohol, smoking, and caffeine in relation to fecundability, with effect modification by NAT2."
25974703,Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
12208565,No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment.
24279859,BDNF rs6265 polymorphism and drug addiction: a systematic review and meta-analysis.
17215846,Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pylori.
17507615,The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers.
17606812,Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
25323806,Effect of CYP2C19 polymorphisms on the clinical outcome of low-dose clobazam therapy in Japanese patients with epilepsy.
24710841,Effectiveness of clopidogrel dose escalation to normalize active metabolite exposure and antiplatelet effects in CYP2C19 poor metabolizers.
28834135,The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized Trial.
18855529,Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following acute coronary syndromes.
22992578,Alleles at rs4273729 in the chromosome 6 do not predict response to peg-interferon-α and ribavirin therapy in hepatitis C virus/HIV-1-coinfected patients.
17724700,UGT2B7 promoter variant -840G&amp;gt;A contributes to the variability in hepatic clearance of morphine in patients with sickle cell disease.
21178985,Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study.
22915658,Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group.
10069510,Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease.
15528295,"The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins."
26880915,Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents.
26801900,Pharmacogenetics driving personalized medicine: analysis of genetic polymorphisms related to breast cancer medications in Italian isolated populations.
22700043,Outcome definitions and clinical predictors influence pharmacogenetic associations between HTR3A gene polymorphisms and response to clozapine in patients with schizophrenia.
24084768,Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects.
17600820,Physiogenomic association of statin-related myalgia to serotonin receptors.
10689270,beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals.
16855453,Phenotype-genotype relationship and clinical effects of citalopram in Chinese patients.
17434921,Association between CYP3A4 genotype and risk of endometrial cancer following tamoxifen use.
18195729,Glycogen synthase kinase-3beta gene is associated with antidepressant treatment response in Chinese major depressive disorder.
17228018,Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors.
22967772,Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.
19606452,"Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients."
28261382,Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C.
23545896,Influence of CYP2D6 and CYP2C19 gene variants on antidepressant response in obsessive-compulsive disorder.
15608561,Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes.
27524899,Long-term administration of escitalopram in patients with social anxiety disorder in Japan.
20386359,"Gene-based warfarin dosing compared with standard of care practices in an orthopedic surgery population: a prospective, parallel cohort study."
30368523,Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African-Americans with opioid use disorder.
18850169,"Coffee, CYP1A2 genotype and risk of myocardial infarction."
25504915,Factors affecting time to maintenance dose in patients initiating warfarin.
24193112,An investigation of CYP2D6 genotype and response to metoprolol CR/XL during dose titration in patients with heart failure: a MERIT-HF substudy.
1356742,Pharmacokinetics and metabolism of the 5-hydroxytryptamine antagonist tropisetron after single oral doses in humans.
26107755,Metabolic side effects and pharmacogenetics of second-generation antipsychotics in children.
19272758,Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.
26820907,"IFNL4 ss469415590 polymorphism contributes to treatment decisions in patients with chronic hepatitis C virus genotype 1b, but not 2a, infection."
24269714,Hydrocodone in postoperative personalized pain management: pro-drug or drug?
20389299,Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism.
23486447,Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.
20981002,Breaking barriers in the genomics and pharmacogenetics of drug addiction.
11791895,The major fluvoxamine metabolite in urine is formed by CYP2D6.
18452396,Serotonin transporter gene polymorphisms and sertraline response in major depression patients.
12825092,Association between A2a receptor gene polymorphisms and caffeine-induced anxiety.
11907712,COLIA1 Sp1 polymorphism predicts response of femoral neck bone density to cyclical etidronate therapy.
12682708,Relationship between clinical effects of fluvoxamine and the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients.
17324110,Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity.
16027735,beta-Blockade and increased dyslipidemia in patients bearing Glu27 variant of beta2 adrenergic receptor gene.
23874514,HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity.
28520348,Mercaptopurine Therapy and &lt;i&gt;TPMT&lt;/i&gt; Genotype
27027531,"IFNL4 polymorphism effects on outcome of simeprevir, peginterferon, and ribavirin therapy for older patients with genotype 1 chronic hepatitis C."
26730167,First-line eradication for Helicobacter pylori-positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype.
21388237,Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.
26227246,Susceptibility loci for heroin and cocaine addiction in the serotonergic and adrenergic pathways in populations of different ancestry.
23478884,Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?
27284960,Risk Factors for Voriconazole-Associated Hepatotoxicity in Patients in the Intensive Care Unit.
15249972,Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate.
11763000,The effect of CYP2C19 and CYP2D6 genotypes on the metabolism of clomipramine in Japanese psychiatric patients.
14070377,RELATIONSHIP BETWEEN  METABOLIC FATES AND ANTITUMOR ACTIVITIES OF THIOPURINES.
23778320,High predictive value of CYP2B6 SNPs for steady-state plasma efavirenz levels in South African HIV/AIDS patients.
29152138,The &lt;i&gt;hOCT1&lt;/i&gt; and &lt;i&gt;ABCB1&lt;/i&gt; polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia.
26104483,HLA-B*58:01 is strongly associated with allopurinol-induced severe cutaneous adverse reactions in Han Chinese patients: a multicentre retrospective case-control clinical study.
15856070,TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia.
28570300,Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia.
28791698,Increased Systemic Exposure and Stronger Cardiovascular and Metabolic Adverse Reactions to Fenoterol in Individuals with Heritable OCT1 Deficiency.
19468717,Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response.
10525111,Thioguanine administered as a continuous intravenous infusion to pediatric patients is metabolized to the novel metabolite 8-hydroxy-thioguanine.
22307138,Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia.
12162507,Two polymorphisms in the vitamin D receptor gene--association with bone mass and 5-year change in bone mass with or without hormone-replacement therapy in postmenopausal women: the Danish Osteoporosis Prevention Study.
15812265,Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism.
26417955,Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing.
20212518,Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project.
20064494,Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin.
15274037,Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders.
23252946,Associations between the genotypes and phenotype of CYP3A and the lipid response to simvastatin in Chinese patients with hypercholesterolemia.
12451290,Evidence of polymorphic CYP2C19 involvement in the human metabolism of N-desmethylclobazam.
28589365,Variability of platelet response to clopidogrel is not related to adverse cardiovascular events in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
25916514,FASTKD2 and human memory: functional pathways and prospects for novel therapeutic target development for Alzheimer's disease and age-associated memory decline.
19297219,Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy.
7885194,"Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes."
26039043,Effects of the CYP3A4*1B Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Adult Renal Transplant Recipients: A Meta-Analysis.
23913015,PharmGKB summary: methylene blue pathway.
18852012,Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
25850030,A prospective randomized evaluation of a pharmacogenomic approach to antiplatelet therapy among patients with ST-elevation myocardial infarction: the RAPID STEMI study.
17654295,Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation.
23609392,Pharmacogenetic study on risperidone long-acting injection: influence of cytochrome P450 2D6 and pregnane X receptor on risperidone exposure and drug-induced side-effects.
24647041,Functional characterization of wild-type and 49 CYP2D6 allelic variants for N-desmethyltamoxifen 4-hydroxylation activity.
11929404,Comparison of lansoprazole and famotidine for gastric acid inhibition during the daytime and night-time in different CYP2C19 genotype groups.
26343256,The impact of CYP2C19 polymorphisms on citalopram metabolism in patients with major depressive disorder.
23730840,Role of IL28B and inosine triphosphatase polymorphisms in the treatment of chronic hepatitis C virus genotype 6 infection.
26109805,β-2 Adrenergic receptor gene polymorphism and response to propranolol in cirrhosis.
22108237,The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients.
15305167,The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes.
17290447,The fatty acid amide hydrolase C385A (P129T) missense variant in cannabis users: studies of drug use and dependence in Caucasians.
21770725,The P450 oxidoreductase *28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5-expressing renal recipients.
20921968,"Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT(3) antagonists tropisetron and ondansetron."
20102306,Pharmacogenetic considerations in the treatment of psychiatric disorders.
27514956,Association of interleukin-28B rs12979860 and rs8099917 polymorphisms with sustained viral response in hepatitis C virus genotype 1 and 3 infected patients from the Indian subcontinent.
15618746,Two novel haplotypes of CYP2D6 gene in a Japanese population.
7903373,"Pharmacokinetics of chlorimipramine, chlorpromazine and their N-dealkylated metabolites in plasma of healthy volunteers after a single oral dose of the parent compounds."
19106083,Genetic determinants of response to clopidogrel and cardiovascular events.
24762860,"Cytochrome p450 gene variants, race, and mortality among clopidogrel-treated patients after acute myocardial infarction."
22390861,High on-treatment platelet reactivity by ADP and increased risk of MACE in good clopidogrel metabolizers.
26230641,Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children.
28763744,Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy.
28525903,"Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia."
22626609,Factors that predict response of patients with hepatitis C virus infection to boceprevir.
27441996,Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
18680467,Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2.
28750137,"Polymorphism of IL10, IL4, CTLA4, and DAO Genes in Cross-Reactive Nonsteroidal Anti-inflammatory Drug Hypersensitivity."
28112181,IL-3 and CTLA4 gene polymorphisms may influence the tacrolimus dose requirement in Chinese kidney transplant recipients.
21317582,Detrimental effect of atazanavir plasma concentrations on total serum bilirubin levels in the presence of UGT1A1 polymorphisms.
30914949,Association Study Among Candidate Genetic Polymorphisms and Chemotherapy-Related Severe Toxicity in Testicular Cancer Patients.
16633140,Risperidone-related weight gain: genetic and nongenetic predictors.
16179085,Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841].
24996380,Comparison of acid inhibition with standard dosages of proton pump inhibitors in relation to CYP2C19 genotype in Japanese.
18581055,An overview of cancer multidrug resistance: a still unsolved problem.
25147095,CYP2B6 c.983T&amp;gt;C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populations.
30664875,A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury.
19800133,Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism.
22584460,"Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin."
22480748,Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis.
28470111,Serum clomipramine and desmethylclomipramine levels in a CYP2C19 and CYP2D6 intermediate metabolizer.
16607077,Interleukin-6 -174 G/C promoter polymorphism and effects of fenofibrate and simvastatin on inflammatory markers in hypercholesterolemic patients.
19119263,G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.
17697139,Influence of CYP2C19 and CYP3A4 gene polymorphisms on clopidogrel responsiveness in healthy subjects.
23132553,Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis.
21325291,A polymorphism in the cytidine deaminase promoter predicts severe capecitabine-induced hand-foot syndrome.
23799528,Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies.
12942574,Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study.
19617864,Interpatient variability in IMPDH activity in MMF-treated renal transplant patients is correlated with IMPDH type II 3757T &amp;gt; C polymorphism.
22310591,Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients.
22474613,HIV-1 antiretroviral drug therapy.
8823236,Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity.
16998491,A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC.
24535487,The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease.
29396738,Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial.
25545243,"Oxidative stress-related genetic polymorphisms are associated with the prognosis of metastatic gastric cancer patients treated with epirubicin, oxaliplatin and 5-fluorouracil combination chemotherapy."
10471060,A new variant CYP2D6 allele (CYP2D6*21) with a single base insertion in exon 5 in a Japanese population associated with a poor metabolizer phenotype.
17387701,Methemoglobinemia and hemolytic anemia caused by rasburicase administration in a newly diagnosed child with Burkitt lymphoma/leukemia.
1247492,Haemolytic effect of two sulphonamides evaluated by a new method.
8648264,Glucose-6-phosphate dehydrogenase deficiency severely restricts the biotransformation of daunorubicin in human erythrocytes.
29474345,Opioid-related genetic polymorphisms do not influence postoperative opioid requirement: A prospective observational study.
14638340,Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection.
20547595,CYP2D6 genotype and smoking influence fluvoxamine steady-state concentration in Japanese psychiatric patients: lessons for genotype-phenotype association study design in translational pharmacogenetics.
23199531,Cytochrome P450-mediated drug metabolism in the brain.
17957182,Acetaminophen reinforces descending inhibitory pain pathways.
29705271,Effects of human SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of acetaminophen and opioid drugs by the cytosolic sulfotransferase SULT1A3.
11516429,The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s).
10091406,(TA)8 allele in the UGT1A1 gene promoter of a Caucasian with Gilbert's syndrome.
20504252,"Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample."
15604515,"APOA5 polymorphisms influence plasma triglycerides in young, healthy African Americans and whites of the CARDIA Study."
25348619,Influence of single-nucleotide polymorphisms on deferasirox C trough levels and effectiveness.
28448657,Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer.
20531370,"Association between CYP2C19*17 and metabolism of amitriptyline, citalopram and clomipramine in Dutch hospitalized patients."
21358750,Nerve growth factor β polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment.
19673941,Effect of R219K polymorphism of the ABCA1 gene on the lipid-lowering effect of pravastatin in Chinese patients with coronary heart disease.
10889531,"Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations."
25495409,Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in Chinese patients with epilepsy.
26637161,UGT1A1 genotype-dependent dose adjustment of belinostat in patients with advanced cancers using population pharmacokinetic modeling and simulation.
25988058,Tumor lysis syndrome and acute anemia in an African-American man with chronic lymphocytic leukemia.
16236141,"Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine."
27533851,Polymorphisms in SLCO1B1 and UGT1A1 are associated with sorafenib-induced toxicity.
11802100,Enantioselective analysis of citalopram and metabolites in adolescents.
22407409,PharmGKB summary:  very important pharmacogene information for CYP3A5.
12966368,"Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus."
27043475,Evaluating the impact of missenses mutations in CYP2D6*7 and CYP2D6*14A: does it compromise tamoxifen metabolism?
21692745,Identification of diuretic non-responders with poor long-term clinical outcomes: a 1-year follow-up of 176 non-azotaemic cirrhotic patients with moderate ascites.
29318929,The pharmacogenetics of medications used in general anesthesia.
27966227,Tacrolimus dose requirements in paediatric renal allograft recipients are characterized by a biphasic course determined by age and bone maturation.
25279974,"Role of SLCO1B1, ABCB1, and CHRNA1 gene polymorphisms on the efficacy of rocuronium in Chinese patients."
24080325,"Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: a meta-analysis based on 23,035 subjects."
18727922,CYP3A53A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia.
19891732,Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction.
15809899,"Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders."
27859023,Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-Analysis.
26902643,Human Genetic Variability Contributes to Postoperative Morphine Consumption.
24322003,Single-nucleotide polymorphisms of ABCG2 increase the efficacy of tyrosine kinase inhibitors in the K562 chronic myeloid leukemia cell line.
28244812,Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing.
25001883,"Pharmacogenetics of warfarin in a paediatric population: time in therapeutic range, initial and stable dosing and adverse effects."
26125934,Correlation of UGT1A1 and ERCC1 gene polymorphisms with the outcome of combined irinotecan plus cisplatin treatment in recurrent ovarian cancer.
23559402,Polymorphisms influencing olanzapine metabolism and adverse effects in healthy subjects.
23323945,Pharmacogenetic analysis in the treatment of Hodgkin lymphoma.
25287681,Detection of allele specific differences in IFNL3 (IL28B) mRNA expression.
25798582,Involvement of cytochrome P450 1A1 and glutathione S-transferase P1 polymorphisms and promoter hypermethylation in the progression of anti-tuberculosis drug-induced liver injury: a case-control study.
11054766,Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study.
22130800,Vitamin K antagonists in children with heart disease: height and VKORC1 genotype are the main determinants of the warfarin dose requirement.
15592325,Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.
22765258,Population pharmacokinetics of unbound mycophenolic acid in adult allogeneic haematopoietic cell transplantation: effect of pharmacogenetic factors.
25398452,Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathy.
20622033,Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis.
26911666,Integrative role of vitamin D related and Interleukin-28B genes polymorphism in predicting treatment outcomes of Chronic Hepatitis C.
16722833,Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes.
2019023,Hemolytic anemia due to G6PD deficiency and urate oxidase in a kidney-transplant patient.
30450628,IL-28β gene polymorphism determines virological response to PEGylated interferon therapy in hepatitis C virus genotype 4 Egyptian patients.
22001987,C3435T polymorphism of the ABCB1 gene: impact on genetic susceptibility to peptic ulcers.
23788015,"PharmGKB summary: Diuretics pathway, pharmacodynamics."
25637052,Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma.
16355252,"Clines, clusters, and the effect of study design on the inference of human population structure."
26729753,Pharmacogenomic Genome-Wide Meta-Analysis of Blood Pressure Response to β-Blockers in Hypertensive African Americans.
24438215,CYP3A5 genotypes affect tacrolimus pharmacokinetics and infectious complications in Chinese pediatric liver transplant patients.
22249355,Pharmacogenetic investigation of response to duloxetine treatment in generalized anxiety disorder.
19959074,Evolving novel anti-HER2 strategies.
23016521,Long-term anticoagulant effects of CYP2C9 and VKORC1 genotypes in phenprocoumon users.
20168265,Influence of serotonin 3A and 3B receptor genes on clozapine treatment response in schizophrenia.
26810137,Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder.
16462814,Overview of the pharmacogenetics of HIV therapy.
21254158,Quantitation of pretreatment serum interferon-γ-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response.
23382909,Glucuronidation by UGT1A1 is the dominant pathway of the metabolic disposition of belinostat in liver cancer patients.
24107802,Hyperbilirubinemia in pazopanib- or sunitinib-treated patients in COMPARZ is associated with UGT1A1 polymorphisms.
22571356,Polymorphisms in VKORC1 have more impact than CYP2C9 polymorphisms on early warfarin International Normalized Ratio control and bleeding rates.
26659468,OCT1 mediates hepatic uptake of sumatriptan and loss-of-function OCT1 polymorphisms affect sumatriptan pharmacokinetics.
19434073,Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
27833958,Clinical importance of pharmacogenetics in the treatment of hepatitis C virus infection.
16863547,The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis.
22974728,"Besides CYP2C19, PON1 genetic variant influences post-clopidogrel platelet reactivity in Chinese patients."
19890249,The role of organic anion-transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics.
23774940,Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: a pharmacogenetics study.
20952418,Tribal ethnicity and CYP2B6 genetics in Ugandan and Zimbabwean populations in the UK: implications for efavirenz dosing in HIV infection.
18253145,Pharmacogenetics: from bench to byte.
17015053,SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin.
18561168,Exchange transfusion as treatment for rasburicase induced methemoglobinemia in a glucose-6-phosphate dehydrogenase deficient patient.
27193993,Deferasirox AUC efficacy cutoff and role of pharmacogenetics.
16450155,"Hydrochlorothiazide efficacy and polymorphisms in ACE, ADD1 and GNB3 in healthy, male volunteers."
9174682,Relationship between fluvoxamine pharmacokinetics and CYP2D6/CYP2C19 phenotype polymorphisms.
19019189,Common candidate gene variants are associated with QT interval duration in the general population.
17616786,Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption.
23371894,Population pharmacokinetic study of memantine: effects of clinical and genetic factors.
26857349,Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network.
14553962,"Effects of endothelial nitric oxide synthase, alpha-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide."
18539621,Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX.
16046221,A genetic variant c.553G &amp;gt; T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population.
19166419,Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis.
23665868,A meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokinetics.
18597649,Genetic variants in FKBP5 affecting response to antidepressant drug treatment.
12883230,Effects of the CYP 2D6 genotype and cigarette smoking on the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients.
16671104,Genetic risk factors associated with lipid-lowering drug-induced myopathies.
28945481,"Long-Term Influence of CYP3A5, CYP3A4, ABCB1, and NR1I2 Polymorphisms on Tacrolimus Concentration in Chinese Renal Transplant Recipients."
26518946,A Simple Novel Technique to Estimate Tacrolimus Dosages During the Early Post Kidney Transplantation Period.
21808284,Gender-stratified gene and gene-treatment interactions in smoking cessation.
17392726,Reversal of opioid-induced bladder dysfunction by intravenous naloxone and methylnaltrexone.
22006096,"Genomics of ADME gene expression: mapping expression quantitative trait loci relevant for absorption, distribution, metabolism and excretion of drugs in human liver."
15168101,"Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting."
22256871,Pharmacogenetics of drugs withdrawn from the market.
24853734,Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metformin.
27997040,Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.
26410689,Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.
26186989,Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
15655011,Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso.
19514130,Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers.
11882573,alpha-Adducin 460Trp allele is associated with erythrocyte Na transport rate in North Sardinian primary hypertensives.
20860463,Influence of host genetic factors on efavirenz plasma and intracellular pharmacokinetics in HIV-1-infected patients.
27399166,Influence of ADORA2A gene polymorphism on leukoencephalopathy risk in MTX-treated pediatric patients affected by hematological malignancies.
20709156,Meta-analysis of FKBP5 gene polymorphisms association with treatment response in patients with mood disorders.
21349923,Seasonal variation in blood drug concentrations and a potential relationship to vitamin D.
21281405,"Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease."
17606663,Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosis.
8554938,An unequal cross-over event within the CYP2D gene cluster generates a chimeric CYP2D7/CYP2D6 gene which is associated with the poor metabolizer phenotype.
19749757,Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.
11823760,The African-specific CYP2D617 allele encodes an enzyme with changed substrate specificity.
12476327,Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders.
18978520,Dose-dependent effect of the CYP2D6 genotype on the steady-state fluvoxamine concentration.
11012469,CYP2C19 genotype status and intragastric pH during dosing with lansoprazole or rabeprazole.
16257277,-511 C/T IL1B gene polymorphism is associated to resistance to bisphosphonates treatment in Paget disease of bone.
15900215,Relative impact of CYP3A genotype and concomitant medication on the severity of atorvastatin-induced muscle damage.
25081908,"Determination of deferasirox plasma concentrations: do gender, physical and genetic differences affect chelation efficacy?"
22190578,Methemoglobinemia induced by rasburicase in a pediatric patient: a case report and literature review.
24014145,Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression.
22955794,Genetic polymorphisms of CYP2C19 influences the response to clopidogrel in ischemic heart disease patients in the South Indian Tamilian population.
28184434,Tell-Tale SNPs: The Role of CYP2B6 in Methadone Fatalities.
12975461,Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma.
18609433,A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.
18221820,Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer.
17233643,"Possible association of beta-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia."
26727275,The COL1A1 SP1 polymorphism is associated with lower bone mineral density in patients treated with valproic acid.
15188945,Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
22795047,Association of APC and REEP5 gene polymorphisms with major depression disorder and treatment response to antidepressants in a Han Chinese population.
25326929,Pharmacogenetic-guided psychiatric intervention associated with increased adherence and cost savings.
27711230,The Role of Hepatitis C Virus Core Antigen Testing in the Era of Direct Acting Antiviral Therapies: What We Can Learn from the Protease Inhibitors.
23651026,CDA gene polymorphisms and enzyme activity: genotype-phenotype relationship in an Italian-Caucasian population.
19303909,Intensity of opiate withdrawal in relation to the 825C&amp;gt;T polymorphism of the G-protein beta 3 subunit gene.
29723928,Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants.
17178267,ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.
21121811,Systematic review of pharmacoeconomic studies of pharmacogenomic tests.
15116054,Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics.
11817517,Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.
26223945,Influence of UDP-Glucuronosyltransferase Polymorphisms on Stable Warfarin Doses in Patients with Mechanical Cardiac Valves.
24019397,CYP2C19 poor metabolizer is associated with clinical outcome of clopidogrel therapy in acute myocardial infarction but not stable angina.
15707415,Consequences of genetic polymorphisms for sirolimus requirements after renal transplant in patients on primary sirolimus therapy.
28612092,Involvement of cytochrome P450 in cisplatin treatment: implications for toxicity.
27143031,Invasive Aspergillus infection requiring lobectomy in a CYP2C19 rapid metabolizer with subtherapeutic voriconazole concentrations.
26951882,Genetic contribution of CYP1A1 variant on treatment outcome in epilepsy patients: a functional and interethnic perspective.
17295875,Cytochrome P450 2C19 polymorphism influences the preventive effect of lansoprazole on the recurrence of erosive reflux esophagitis.
26699619,Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.
27995989,Pharmacogenetic variants associated with outcome in patients with advanced gastric cancer treated with fluoropyrimidine and platinum-based triplet combinations: a pooled analysis of three prospective studies.
9653159,Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?
26340055,Epigenomic mapping and effect sizes of noncoding variants associated with psychotropic drug response.
18279474,Serotonin transporter polymorphism and bleeding time during SSRI therapy.
9857976,Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine.
19925424,Arrhythmia pharmacogenomics: methodological considerations.
20826553,Variation in GNB3 predicts response and adverse reactions to antidepressants.
21962566,Association between serotonin transporter gene promoter-region polymorphism and 4- and 12-week treatment response to sertraline in posttraumatic stress disorder.
21851379,The effects of a single nucleotide polymorphism in SLCO1B1 on the pharmacodynamics of pravastatin.
8841196,Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene.
27043265,Role of pharmacogenetics on deferasirox AUC and efficacy.
25367448,FTO rs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients.
9316174,"Effects of genetic defects in the CYP2C19 gene on the N-demethylation of imipramine, and clinical outcome of imipramine therapy."
2502894,Aspirin-induced acute haemolytic anaemia in glucose-6-phosphate dehydrogenase-deficient children with systemic arthritis.
20403483,Effect of pravastatin therapy on coronary events in carriers of the KIF6 719Arg allele from the cholesterol and recurrent events trial.
23288236,"5-HTTLPR rs25531A &amp;gt; G differentially influence paroxetine and fluvoxamine antidepressant efficacy: a randomized, controlled trial."
19458626,SNP analyses in cytarabine metabolizing enzymes in AML patients and their impact on treatment response and patient survival: identification of CDA SNP C-451T as an independent prognostic parameter for survival.
8667235,"The biotransformation of clomipramine in vitro, identification of the cytochrome P450s responsible for the separate metabolic pathways."
16115483,The -514C/T polymorphism of the hepatic lipase gene significantly modulates the HDL-cholesterol response to statin treatment.
23384627,Methacholine PC20 in African Americans and whites with asthma with homozygous genotypes at ADRB2 codon 16.
18722008,Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial.
26111151,PharmGKB summary: peginterferon-α pathway.
23623526,Association of CYP2C19 polymorphisms and lansoprazole-associated respiratory adverse effects in children.
24658827,"The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients."
17190370,Influence of ABCB1 C3435T polymorphism on the pharmacokinetics of lansoprazole and gastroesophageal symptoms in Japanese renal transplant recipients classified as CYP2C19 extensive metabolizers and treated with tacrolimus.
21902501,Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients.
21806387,Impact of genetic variants on post-clopidogrel platelet reactivity in patients after elective percutaneous coronary intervention.
8169844,Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
21142914,SLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients.
24625991,The impact of genetic polymorphisms on time required to attain the target tacrolimus levels and subsequent pharmacodynamic outcomes in pediatric kidney transplant patients.
12811365,Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics.
18695978,Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation.
27262824,"Effect of VKORC1, CYP2C9, CFP4F2, and GGCX Gene Polymorphisms on Warfarin Dose in Japanese Pediatric Patients."
7859811,Glucuronidation clearance of 8-hydroxyclomipramine in relation to sparteine and mephenytoin phenotype.
27385990,Prospective study of the UGT1A1*27 gene polymorphism during irinotecan therapy in patients with lung cancer: Results of Lung Oncology Group in Kyusyu (LOGIK1004B).
12563174,The Gln27Glu beta2-adrenoceptor polymorphism slows the onset of desensitization of cardiac functional responses in vivo.
27798726,Genomic sequencing of uric acid metabolizing and clearing genes in relationship to xanthine oxidase inhibitor dose.
25621429,"Individualized Hydrocodone Therapy Based on Phenotype, Pharmacogenetics, and Pharmacokinetic Dosing."
23150149,NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapy.
17700364,Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.
23013460,Apnea and oxygen desaturations in children treated with opioids after adenotonsillectomy for obstructive sleep apnea syndrome: a prospective pilot study.
28370399,Brisk clinical response to erythrocytapheresis in a G6PD-deficient patient with rasburicase-induced methemoglobinemia.
23652803,"Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia."
23974086,"Effect of CYP3A4*22, POR*28, and PPARA rs4253728 on sirolimus in vitro metabolism and trough concentrations in kidney transplant recipients."
10793824,Haemolytic potential of three chemotherapeutic agents and aspirin in glucose-6-phosphate dehydrogenase deficiency.
17189961,Diuretic-gene interaction and the risk of myocardial infarction and stroke.
23703421,The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
16678544,Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin.
19996755,Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms.
28261910,A systematic review and meta-analysis of HCV clearance.
19020788,Vitamin D receptor gene polymorphisms predict acquired resistance to clodronate treatment in patients with Paget's disease of bone.
21436344,"Pharmacogenetics, pharmacogenomics, and individualized medicine."
22304580,Cytidine deaminase genetic variants influence RNA expression and cytarabine cytotoxicity in acute myeloid leukemia.
9878993,Efavirenz.
28745577,Advanced cancer pain: the search for genetic factors correlated with interindividual variability in opioid requirement.
22076562,Evaluation of lansoprazole as a probe for assessing cytochrome P450 2C19 activity and genotype-phenotype correlation in childhood.
18222355,Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study.
28006928,Sufentanil and midazolam dosing and pharmacogenetic factors in pediatric analgosedation and withdrawal syndrome.
23233662,Genome-wide study of methotrexate clearance replicates SLCO1B1.
27058899,eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study.
28592190,Genetic variants associated with warfarin dosage in Kuwaiti population.
25918016,Interleukin 28B polymorphisms as predictors of sustained virological response in chronic hepatitis C: systematic review and meta-analysis.
1527229,Debrisoquine hydroxylation phenotypes of patients with high versus low to normal serum antidepressant concentrations.
22015451,A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome.
19390945,UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients.
30304062,KIF6 gene as a pharmacogenetic marker for lipid-lowering effect in statin treatment.
26799749,New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugs.
24113216,Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus.
26463708,Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy.
20938465,Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype.
10758249,"Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders."
21951981,IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C.
21357676,Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption.
27324805,Pharmacogenetics of citalopram-related side effects in children with depression and/or anxiety disorders.
22543981,Pharmacogenetics and healthcare outcomes in patients with chronic heart failure.
17226852,Oral anticoagulation with warfarin is significantly influenced by steroids and CYP2C9 polymorphisms in children with cancer.
26461463,Pharmacokinetics of metoprolol during pregnancy and lactation.
23071495,"Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms."
24444408,"CYP3A5 and CYP3A4, but not ABCB1 polymorphisms affect tacrolimus dose-adjusted trough concentrations in kidney transplant recipients."
23677058,Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia.
19802338,"Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication."
25292429,Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
12925557,The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition.
22775532,The AmpliChip® CYP450 test and response to treatment in schizophrenia and obsessive compulsive disorder: a pilot study and focus on cases with abnormal CYP2D6 drug metabolism.
26771271,The Gly16 Allele of the Gly16Arg Single-Nucleotide Polymorphism in the β₂-Adrenergic Receptor Gene Augments Perioperative Use of Vasopressors: A Retrospective Cohort Study.
20965456,Pilot study of the antiplatelet effect of increased clopidogrel maintenance dosing and its relationship to CYP2C19 genotype in patients with high on-treatment reactivity.
19512956,Antiestrogen pathway (aromatase inhibitor).
27955884,Pharmacogenetics-guided analgesics in major abdominal surgery: Further benefits within an enhanced recovery protocol.
29668752,The CYP1A2 -163C&amp;gt;A polymorphism does not alter the effects of caffeine on basketball performance.
23510446,Additive effects of 5-HTTLPR (serotonin transporter) and tryptophan hydroxylase 2 G-703T gene polymorphisms on the clinical response to citalopram among children and adolescents with depression and anxiety disorders.
20800921,Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury.
22438096,"Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus."
24663076,"Effect of CYP2D6, CYP2C9 and ABCB1 genotypes on fluoxetine plasma concentrations and clinical improvement in children and adolescent patients."
27790931,The path to implementation of personalized medicine of aromatase inhibitors in patients with breast cancer.
21094359,"Effect of central obesity, low high-density lipoprotein cholesterol and C-reactive protein polymorphisms on C-reactive protein levels during treatment with Rosuvastatin (10 mg Daily)."
28638221,Prevalence of &lt;i&gt;IFNL3&lt;/i&gt; rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C.
28689274,Impact of glutathione transferases genes polymorphisms in nevirapine adverse reactions: a possible role for GSTM1 in SJS/TEN susceptibility.
26491254,A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis.
23962279,Implementation of TPMT testing.
24117654,Impact of IL28B polymorphisms on 24-week telaprevir-based combination therapy for Asian chronic hepatitis C patients with hepatitis C virus genotype 1b.
28605058,Cardiovascular Pharmacogenomics and Cognitive Function in Patients with Schizophrenia.
15726636,Functional analysis of CYP2D6.31 variant: homology modeling suggests possible disruption of redox partner interaction by Arg440His substitution.
18983505,Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism.
27767376,Pharmacogenomics and histone deacetylase inhibitors.
19056598,"Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states."
16400613,A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency.
19833260,The SLCO1B1*5 genetic variant is associated with statin-induced side effects.
18086475,Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting.
21950502,British Association of Dermatologists' guidelines for the safe and effective prescribing of azathioprine 2011.
25534433,Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes.
15024131,Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant.
17467808,Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.
18987562,Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder.
26196596,Genotype-guided dose adjustment for the use of efavirenz in HIV treatment.
19077919,Effect of CYP2C9 and VKORC1 genotypes on early-phase and steady-state warfarin dosing in Korean patients with mechanical heart valve replacement.
21688171,Determinants of pharmacodynamic trajectory of the therapeutic response to paroxetine in Japanese patients with panic disorder.
14624186,5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study.
12608943,Effectiveness of alendronate treatment in postmenopausal women with osteoporosis: relationship with BsmI vitamin D receptor genotypes.
12075750,"Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol."
28135763,The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study.
22776642,Arylamine N-acetyltransferases--from drug metabolism and pharmacogenetics to identification of novel targets for pharmacological intervention.
15927391,The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients.
21726252,IL28B rs12979860 C/T polymorphism in elderly chronic hepatitis C patients treated with pegylated-interferon and ribavirin.
17485248,CoQ10 deficiency diseases in adults.
20056557,Mu-opioid receptors are not necessary for nortriptyline treatment of neuropathic allodynia.
28705252,"Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial."
9429236,Meta-analysis of phenotype and genotype of NAT2 deficiency in Chinese populations.
25611810,Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa.
21993426,Genetic variants of interferon-stimulated genes and IL-28B as host prognostic factors of response to combination treatment for chronic hepatitis C.
11926892,"Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension."
12497624,D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes.
18591455,Physiological interaction between alpha-adducin and WNK1-NEDD4L pathways on sodium-related blood pressure regulation.
29290749,Rasburicase-induced Hemolytic Anemia in an Adolescent With Unknown Glucose-6-Phosphate Dehydrogenase Deficiency.
19259652,Genetic and pharmacokinetic factors affecting the initial pharmacotherapeutic effect of paroxetine in Japanese patients with panic disorder.
22354160,"Associations between ABCB1, CYP2A6, CYP2B6, CYP2D6, and CYP3A5 alleles in relation to efavirenz and nevirapine pharmacokinetics in HIV-infected individuals."
21192344,CYP2C19 variation and citalopram response.
7598739,In vitro characterization of cytochrome P450 catalysed metabolism of the antiemetic tropisetron.
20173735,ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C.
18784265,"Functional characterization of 17 CYP2D6 allelic variants (CYP2D6.2, 10, 14A-B, 18, 27, 36, 39, 47-51, 53-55, and 57)."
22680342,Influence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV-positive patients using dried sample spot devices.
21441248,Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals.
20887379,Tumour necrosis factor haplotypes associated with sensory neuropathy in Asian and Caucasian human immunodeficiency virus patients.
26401760,BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependence.
26779253,An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients.
11927765,Med-psych drug-drug interactions update.
12920424,Adverse drug reactions to oxycodone and hydrocodone in CYP2D6 ultrarapid metabolizers.
12065438,CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes.
22092036,"Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes."
27511999,Factors influencing quality of anticoagulation control and warfarin dosage in patients after aortic valve replacement within the 3 months of follow up.
28072888,Clinical and virological predictors of sustained response with an interferon-based simeprevir regimen for patients with chronic genotype 1 hepatitis C virus infection.
23778326,A search for new CYP3A4 variants as determinants of tacrolimus dose requirements in renal-transplanted patients.
7060320,Influence of double genetic polymorphism on response to sulfamethazine.
28409297,The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries.
28762371,"Imatinib-induced ophthalmological side-effects in GIST patients are associated with the variations of EGFR, SLC22A1, SLC22A5 and ABCB1."
19193342,Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.
21912424,CYP4A11 variant is associated with high-density lipoprotein cholesterol in women.
27388970,The role of cytochrome P450 pharmacogenomics in chronic non-cancer pain patients.
23612435,An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.
27091191,A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study.
17918089,Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P450 2B6 *6 and *26.
21215785,Uniform assessment and ranking of opioid μ receptor binding constants for selected opioid drugs.
23423913,Mechanical heart valve recipients: anticoagulation in patients with genetic variations of phenprocoumon metabolism.
25730298,The Effect of β2-Adrenoceptor Genotype on Phenylephrine Dose Administered During Spinal Anesthesia for Cesarean Delivery.
27977511,Rituximab response in follicular lymphoma is associated with the rs20575 polymorphism in TRAILR1 extrinsic apoptosis trigger.
29844858,Genetic polymorphism of &lt;i&gt;SLC31A1&lt;/i&gt; is associated with clinical outcomes of platinum-based chemotherapy in non-small-cell lung cancer patients through modulating microRNA-mediated regulation.
12662378,"Lafutidine, a novel histamine H2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori."
29061085,Do genes affect morphine response?
27988869,Comparative Pharmacology and Guide to the Use of the Serotonin 5-HT&lt;sub&gt;3&lt;/sub&gt; Receptor Antagonists for Postoperative Nausea and Vomiting.
23065688,Glutathione S-transferase P1 single nucleotide polymorphism predicts permanent ototoxicity in children with medulloblastoma.
24504666,Positive clinical response to clopidogrel is independent of paraoxonase 1 Q192R and CYP2C19 genetic variants.
24549002,Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients.
19997080,Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions.
22676193,UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients.
15608559,The human serotonin receptor 2B: coding region polymorphisms and association with vulnerability to illegal drug abuse.
19448608,Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21.
26369612,Pharmacogenomics and cardiology: improving treatment with existing drugs.
24598718,Identification of the effect of multiple polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid using a population-modeling approach.
25171759,The MYLIP p.N342S polymorphism is associated with response to lipid-lowering therapy in Brazilian patients with familial hypercholesterolemia.
20640435,Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?
25556837,"Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity."
8033754,The dopamine D2 receptor gene: a genetic risk factor in substance abuse.
27261829,Pharmacogenetics of Potassium Channel Blockers.
23707372,Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapy.
21348813,Short communication: use of serum bilirubin levels as surrogate marker of early virological response to atazanavir-based antiretroviral therapy.
24704000,Assessment of clinical outcomes in breast cancer patients treated with taxanes: multi-analytical approach.
18518849,Pharmacogenetics of Gilbert's syndrome.
20196170,A ghostly presence-G6PD deficiency.
19752398,"Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly."
24616296,"Adoption of a clinical pharmacogenomics implementation program during outpatient care--initial results of the University of Chicago ""1,200 Patients Project""."
12082589,"Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response."
22012471,"ADORA2A Gene variation, caffeine, and emotional processing: a multi-level interaction on startle reflex."
25869015,Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study.
18004210,"Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients."
29723426,CYP2C19 or CYP3A5 Genotyping Does Not Predict Clinical Response to Clopidogrel.
19567893,Moderation of antidepressant response by the serotonin transporter gene.
24024897,RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients.
15554460,Beta2 adrenergic receptor gene Arg16Gly polymorphism is associated with therapeutic efficacy of benazepril on essential hypertension in Chinese.
30520364,Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials.
11866001,A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.
30300922,Influence of OCT1 Ontogeny and Genetic Variation on Morphine Disposition in Critically Ill Neonates: Lessons From PBPK Modeling and Clinical Study.
23859569,OCT1 genetic variants influence the pharmacokinetics of morphine in children.
17495880,CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients.
26678969,Clinical Implications of Opioid Pharmacogenomics in Patients With Cancer.
23059146,CYP2D6 genotype information to guide pimozide treatment in adult and pediatric patients: basis for the U.S. Food and Drug Administration's new dosing recommendations.
28694205,Association of variants in SH2B1 and RABEP1 with worsening of low-density lipoprotein and glucose parameters in patients treated with psychotropic drugs.
11692084,In-vitro analysis of the contribution of CYP2D6.35 to ultra-rapid metabolism.
18547065,Machine learning methods and docking for predicting human pregnane X receptor activation.
7507039,"Tropisetron. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as an antiemetic."
26107754,Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation.
21753748,Genetic influence in statin intolerance.
17434923,Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2.
24750455,Rasburicase-induced methemoglobinemia in two African-American female patients: an under-recognized and continued problem.
25148458,Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics.
26458301,Influence of CYP3A5 genetic variation on everolimus maintenance dosing after cardiac transplantation.
19936169,Drospirenone/ethinyl estradiol 3 mg/20 mug (24/4 day regimen): hormonal contraceptive choices - use of a fourth-generation progestin.
21174619,"VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study."
12544691,Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan.
18466100,Impact of CYP2C19 polymorphisms on the efficacy of clobazam therapy.
18815589,A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study.
79931,Haemoglobinopathies and G.-6-P.D. deficiency in Laos.
19659438,"CYP2B6 variants and plasma efavirenz concentrations during antiretroviral therapy in Port-au-Prince, Haiti."
27488176,Genetic determinants of warfarin maintenance dose and time in therapeutic treatment range: a RE-LY genomics substudy.
18443790,Vitamin D receptor genotypes and response to zoledronic acid therapy in thalassemia-induced osteoporosis.
19228205,Cytochrome P450 2B6 516G--&amp;gt;T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population.
22992668,Pharmacogenomics knowledge for personalized medicine.
12439223,Pharmacogenetic investigation of smoking cessation treatment.
19371316,CYP2B6 (c.516G--&amp;gt;T) and CYP2A6 (*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients.
29399716,Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus.
16609363,Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir.
22210422,Impact of CYP3A5 genotype of recipients as well as donors on the tacrolimus pharmacokinetics and infectious complications after living-donor liver transplantation for Japanese adult recipients.
23530079,An in vivo drug screening model using glucose-6-phosphate dehydrogenase deficient mice to predict the hemolytic toxicity of 8-aminoquinolines.
24481458,Fat mass- and obesity-associated (FTO) gene and antipsychotic-induced weight gain: an association study.
15483195,In vitro characterization of clobazam metabolism by recombinant cytochrome P450 enzymes: importance of CYP2C19.
23133602,Pharmacogenetics of efficacy and safety of HCV treatment in HCV-HIV coinfected patients: significant associations with IL28B and SOCS3 gene variants.
25185591,Catechol-o-methyltransferase polymorphisms predict opioid consumption in postoperative pain.
19667110,Identification of genetic variants associated with response to statin therapy.
25115434,CYP2C19*17 increases clopidogrel-mediated platelet inhibition but does not alter the pharmacokinetics of the active metabolite of clopidogrel.
21398039,Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients.
22723959,Paraoxonase-1 is not a major determinant of stent thrombosis in a Taiwanese population.
21068134,HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy.
24703092,"Influence of UGT2B7, OPRM1 and ABCB1 gene polymorphisms on postoperative morphine consumption."
19654083,[A severe G6PD deficiency revealed during a chemotherapy protocol including rasburicase].
10375803,Clomipramine N-demethylation metabolism in human liver microsomes.
17622941,Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants.
10471072,A rare G2061 insertion affecting the open reading frame of CYP2D6 and responsible for the poor metabolizer phenotype.
25898045,Neurotoxicity of generic anesthesia agents in infants and children: an orphan research question in search of a sponsor.
16103896,An association study of 43 SNPs in 16 candidate genes with atorvastatin response.
16522833,"Coffee, CYP1A2 genotype, and risk of myocardial infarction."
25851472,Patients with both CYP2C19 loss-of-function allele and peripheral endothelial dysfunction are significantly correlated with adverse cardiovascular events following coronary stent implantation.
25069381,Mechanisms and assessment of statin-related muscular adverse effects.
16609067,FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma.
19018870,FCGR3A-158V/F polymorphism may correlate with the levels of immunoglobulin in patients with non-Hodgkin's lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation.
23773341,An opposite-direction modulation of the COMT Val158Met polymorphism on the clinical response to intrathecal morphine and triptans.
19747927,Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients.
29432897,Bleeding predictors in patients following venous thromboembolism treated with vitamin K antagonists: Association with increased number of single nucleotide polymorphisms.
20523342,IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population.
22547144,"The PPAR alpha gene is associated with triglyceride, low-density cholesterol and inflammation marker response to fenofibrate intervention: the GOLDN study."
20809084,Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients.
26469045,Pharmacogenomics in the clinic.
23119086,Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate.
26004431,SLC47A1 gene rs2289669 G&amp;gt;A variants enhance the glucose-lowering effect of metformin via delaying its excretion in Chinese type 2 diabetes patients.
19034036,The beta2 adrenergic receptor Gln27Glu polymorphism affects insulin resistance in patients with heart failure: possible modulation by choice of beta blocker.
23095326,Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.
19606088,Increased mycophenolic acid exposure in stable kidney transplant recipients on tacrolimus as compared with those on sirolimus: implications for pharmacokinetics.
26670100,"Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study."
27027462,Genetic Predisposition to Poor Opioid Response in Preterm Infants: Impact of KCNJ6 and COMT Polymorphisms on Pain Relief After Endotracheal Intubation.
9738510,An Sp1 binding site polymorphism in the COLIA1 gene predicts osteoporotic fractures in both men and women.
10653220,Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene.
15453913,Single nucleotide polymorphisms in the apolipoprotein B and low density lipoprotein receptor genes affect response to antihypertensive treatment.
19779319,"CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patients."
25303292,Pharmacogenomic testing: the case for CYP2C19 proton pump inhibitor gene-drug pairs.
18070221,"Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants."
9259381,High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers.
26830411,Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients.
20877298,The genetics of loop diuretic effects.
19676097,FKBP5 polymorphisms and antidepressant response in geriatric depression.
15564878,The T341C (Ile114Thr) polymorphism of N-acetyltransferase 2 yields slow acetylator phenotype by enhanced protein degradation.
17722074,Pharmacogenetics of morphine: Potential implications in sickle cell disease.
29755652,Correlation of MDR1 gene polymorphism with propofol combined with remifentanil anesthesia in pediatric tonsillectomy.
19604091,Utilization of pharmacogenomics and therapeutic drug monitoring for opioid pain management.
23305245,Trimethoprim-metformin interaction and its genetic modulation by OCT2 and MATE1 transporters.
23492908,Influence of CYP1A1/CYP1A2 and AHR polymorphisms on systemic olanzapine exposure.
22088980,Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease.
26991336,The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children.
15226675,"High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)."
10683861,Serotonin transporter gene polymorphism and antidepressant response.
17766366,Genetic risk for metabolic syndrome: examination of candidate gene polymorphisms related to lipid metabolism in Japanese people.
26071337,Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment.
19207029,Common sequence variant in lipoprotein lipase gene conferring triglyceride response to fibrate treatment.
18021981,Possible association of CTLA-4 gene polymorphism with cyclosporine-induced gingival overgrowth in kidney transplant recipients.
24892773,PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2.
15284534,Lipid-lowering response to statins is affected by CYP3A5 polymorphism.
24836897,Urinary hydrocodone and metabolite distributions in pain patients.
23166513,RHOA is a modulator of the cholesterol-lowering effects of statin.
16170755,Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia.
24345815,Effects of CYP2C19 and P450 oxidoreductase polymorphisms on the population pharmacokinetics of clobazam and N-desmethylclobazam in japanese patients with epilepsy.
24816252,An atlas of genetic influences on human blood metabolites.
20473659,"Discovery of the nonfunctional CYP2D6 31 allele in Spanish, Puerto Rican, and US Hispanic populations."
19576320,Relation of genetic polymorphisms in the cytochrome P450 gene with clopidogrel resistance after drug-eluting stent implantation in Koreans.
25495407,SNPs and taxane toxicity in breast cancer patients.
9103485,Inhibition of cytochrome P450 2D6 metabolism of hydrocodone to hydromorphone does not importantly affect abuse liability.
10353456,A puzzling case of seizures and visual hallucinations during clomipramine treatment with a high dose but causing a low serum concentration.
27740732,Identification of novel variants associated with warfarin stable dosage by use of a two-stage extreme phenotype strategy.
29454235,Donor and recipient P450 gene polymorphisms influence individual pharmacological effects of tacrolimus in Chinese liver transplantation patients.
24217698,Population pharmacokinetic and pharmacogenetic analysis of nevirapine in hypersensitive and tolerant HIV-infected patients from Malawi.
23733030,Pharmacogenetics in major depression: a comprehensive meta-analysis.
27422302,SLC29A1 (ENT1) polymorphisms and outcome of complete remission in acute myeloid leukemia.
18509327,Pharmacogenetic pathway analysis of docetaxel elimination.
21689142,Pharmacokinetics and pharmacodynamics following maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variants.
12656699,The effects of lansoprazole on erosive reflux oesophagitis are influenced by CYP2C19 polymorphism.
24316028,The role of genetic polymorphisms in cytochrome P450 and effects of tuberculosis co-treatment on the predictive value of CYP2B6 SNPs and on efavirenz plasma levels in adult HIV patients.
27541716,Loss-of-function polymorphisms in the organic cation transporter OCT1 are associated with reduced postoperative tramadol consumption.
16645157,Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel.
20048079,Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors.
20347093,Genetic involvement in statins induced myopathy. Preliminary data from an observational case-control study.
23252947,Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.
21723677,The aldehyde dehydrogenase 2 gene is associated with heroin dependence.
7693389,CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphone.
15565110,Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment.
25889207,"CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe."
23686330,Genetic variability at COMT but not at OPRM1 and UGT2B7 loci modulates morphine analgesic response in acute postoperative pain.
28243137,Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6.
15590749,"Amitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapy."
16204390,Hemolysis and methemoglobinemia secondary to rasburicase administration.
29352482,Influence of pharmacogenetic polymorphisms and demographic variables on metformin pharmacokinetics in an admixed Brazilian cohort.
23666564,Influence of CYP2C19 polymorphism and concomitant antiepileptic drugs on serum clobazam and N-desmethyl clobazam concentrations in patients with epilepsy.
25042728,Genetic determinants of acenocoumarol and warfarin maintenance dose requirements in Slavic population: a potential role of CYP4F2 and GGCX polymorphisms.
28302415,"A prospective study to assess the association between genotype, phenotype and Prakriti in individuals on phenytoin monotherapy."
21121776,Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis.
17702092,HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis.
22374717,Clarifying the importance of CYP2C19 and PON1 in the mechanism of clopidogrel bioactivation and in vivo antiplatelet response.
28186161,Genetic variants in interferon-λ 4 influences HCV clearance in Chinese Han population.
23613831,"The KCNH2 genetic polymorphism (1956, C&amp;gt;T) is a novel biomarker that is associated with CCB and α,β-ADR blocker response in EH patients in China."
14729419,Unusual side-effects due to clobazam: a case report with genetic study of CYP2C19.
17015049,Orosomucoid (alpha1-acid glycoprotein) plasma concentration and genetic variants: effects on human immunodeficiency virus protease inhibitor clearance and cellular accumulation.
20504256,Personalized therapy in pain management: where do we stand?
20179710,Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide.
16272958,"Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavirenz."
24262617,Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
26715213,"Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naïve HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study."
10961881,Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment.
20530282,Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.
19749758,IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.
22328925,Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients.
19590397,"5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression."
20876785,In vitro cytochrome P450-mediated metabolism of exemestane.
24589908,The c.480C&amp;gt;G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia.
29318894,Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients.
11547828,Association of collagen Ialpha 1 Sp1 polymorphism with the risk of prevalent fractures: a meta-analysis.
9261824,Association between a delta opioid receptor gene polymorphism and heroin dependence in man.
12810179,Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture.
25712182,"Effect of clinical factors and gene polymorphism of CYP2C19*2, *17 and CYP4F2*3 on early stent thrombosis."
26265436,Serotonergic gene variation in substance use pharmacotherapy: a systematic review.
29061087,OCT1 pharmacogenetics in pain management: is a clinical application within reach?
9517369,Non-linear fluvoxamine disposition.
24126707,Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females.
18698879,Pharmacogenetics of oral anticoagulants: a basis for dose individualization.
22592842,Oral anticoagulation and VKORC1 polymorphism in patients with a mechanical heart prosthesis: a 6-year follow-up.
17671401,Beta-2-adrenergic receptor polymorphisms and changes in lipids induced by metoprolol.
25939711,Steady-state pharmacokinetics of metformin is independent of the OCT1 genotype in healthy volunteers.
26894931,Cyclophosphamide treatment-induced leukopenia rates in ANCA-associated vasculitis are influenced by variant CYP450 2C9 genotypes.
28379874,Effects of Single Nucleotide Polymorphisms on Surgical and Postsurgical Opioid Requirements: A Systematic Review and Meta-Analysis.
28819312,Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles.
26267224,Dissecting ancestry genomic background in substance dependence genome-wide association studies.
4574753,A comparative evaluation of sulfalene-trimethoprim and sulphormethoxine-pyrimethamine against falciparum malaria in Thailand.
16580768,Serotonin transporter polymorphisms and clinical response to sertraline across ethnicities.
24071851,Emerging landscape of oncogenic signatures across human cancers.
22951632,Underlying genetic structure impacts the association between CYP2B6 polymorphisms and response to efavirenz and nevirapine.
23726091,Genetic determinants of high on-treatment platelet reactivity in clopidogrel treated Chinese patients.
19074728,Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy.
15650881,Ile118Val genetic polymorphism of CYP3A4 and its effects on lipid-lowering efficacy of simvastatin in Chinese hyperlipidemic patients.
15900213,Genetic variation in the bleomycin hydrolase gene and bleomycin-induced pulmonary toxicity in germ cell cancer patients.
25893859,Elucidating the genomic landscape of breast cancer: how will this affect treatment?
29791011,A Pharmacokinetic and Pharmacogenetic Analysis of Osteosarcoma Patients Treated With High-Dose Methotrexate: Data From the OS2006/Sarcoma-09 Trial.
21121773,Genetic polymorphisms in sex hormone metabolizing genes and drug response in women with epilepsy.
23302985,The effect of OPRM1 and COMT genotypes on the analgesic response to intravenous fentanyl labor analgesia.
21361732,Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication.
12042669,"Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients."
24279860,Genetics of antipsychotic-induced weight gain: update and current perspectives.
10692979,VDR genotype and response to etidronate therapy in late postmenopausal women.
16948615,"Pharmacogenetics and pharmacogenomics: development, science, and translation."
25155930,Voriconazole and atazanavir: a CYP2C19-dependent manageable drug-drug interaction.
12386647,Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole.
21063236,"Dependency of phenprocoumon dosage on polymorphisms in the VKORC1, CYP2C9, and CYP4F2 genes."
16205777,Polymorphisms in the 5-hydroxytryptamine 2A receptor and CytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in japanese depressed patients.
17457342,Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin.
11755554,Caffeine metabolism and the risk of spontaneous abortion of normal karyotype fetuses.
24710841,Effectiveness of clopidogrel dose escalation to normalize active metabolite exposure and antiplatelet effects in CYP2C19 poor metabolizers.
24217698,Population pharmacokinetic and pharmacogenetic analysis of nevirapine in hypersensitive and tolerant HIV-infected patients from Malawi.
20130494,Association of common variants of CYP4A11 and CYP4F2 with stroke in the Han Chinese population.
24101478,Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity.
26491254,A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis.
18322281,Genetic determinants of response to warfarin during initial anticoagulation.
26109805,β-2 Adrenergic receptor gene polymorphism and response to propranolol in cirrhosis.
28448657,Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer.
18855529,Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following acute coronary syndromes.
25974703,Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
25367448,FTO rs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients.
17485248,CoQ10 deficiency diseases in adults.
29844858,Genetic polymorphism of &lt;i&gt;SLC31A1&lt;/i&gt; is associated with clinical outcomes of platinum-based chemotherapy in non-small-cell lung cancer patients through modulating microRNA-mediated regulation.
26977146,The Impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 Polymorphisms on Metformin Therapeutic Efficacy in Chinese Type 2 Diabetes Patients.
21912424,CYP4A11 variant is associated with high-density lipoprotein cholesterol in women.
28745549,Prior opioid exposure influences parents' sharing of their children's CYP2D6 research results.
26710337,A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial Fibrillation.
27767376,Pharmacogenomics and histone deacetylase inhibitors.
27247849,Genetic variation and cognitive dysfunction in opioid-treated patients with cancer.
26779253,An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients.
27966227,Tacrolimus dose requirements in paediatric renal allograft recipients are characterized by a biphasic course determined by age and bone maturation.
18680467,Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2.
19924111,"Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment."
19057464,Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.
21357676,Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption.
22293536,PharmGKB summary:  caffeine pathway.
19056598,"Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states."
23612435,An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.
23382909,Glucuronidation by UGT1A1 is the dominant pathway of the metabolic disposition of belinostat in liver cancer patients.
20523342,IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population.
22328925,Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients.
8554938,An unequal cross-over event within the CYP2D gene cluster generates a chimeric CYP2D7/CYP2D6 gene which is associated with the poor metabolizer phenotype.
23071495,"Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms."
25504915,Factors affecting time to maintenance dose in patients initiating warfarin.
25545243,"Oxidative stress-related genetic polymorphisms are associated with the prognosis of metastatic gastric cancer patients treated with epirubicin, oxaliplatin and 5-fluorouracil combination chemotherapy."
28261382,Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C.
16201835,A C1173T dimorphism in the VKORC1 gene determines coumarin sensitivity and bleeding risk.
27859023,Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-Analysis.
26670100,"Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study."
27524899,Long-term administration of escitalopram in patients with social anxiety disorder in Japan.
28244812,Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing.
20048079,Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors.
24019752,CYP2C19 polymorphisms in the Thai population and the clinical response to clopidogrel in patients with atherothrombotic-risk factors.
18838503,"Expression and functional analysis of CYP2D6.24, CYP2D6.26, CYP2D6.27, and CYP2D7 isozymes."
23132553,Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis.
25115783,Methaemoglobinaemia in a G6PD-deficient child treated with rasburicase.
23530079,An in vivo drug screening model using glucose-6-phosphate dehydrogenase deficient mice to predict the hemolytic toxicity of 8-aminoquinolines.
9517369,Non-linear fluvoxamine disposition.
18330458,Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients.
19512956,Antiestrogen pathway (aromatase inhibitor).
22765258,Population pharmacokinetics of unbound mycophenolic acid in adult allogeneic haematopoietic cell transplantation: effect of pharmacogenetic factors.
23384627,Methacholine PC20 in African Americans and whites with asthma with homozygous genotypes at ADRB2 codon 16.
25001883,"Pharmacogenetics of warfarin in a paediatric population: time in therapeutic range, initial and stable dosing and adverse effects."
24353446,"Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel response."
26880915,Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents.
19925424,Arrhythmia pharmacogenomics: methodological considerations.
26857349,Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network.
25069381,Mechanisms and assessment of statin-related muscular adverse effects.
16722833,Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes.
18070221,"Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants."
14998425,CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes.
19019189,Common candidate gene variants are associated with QT interval duration in the general population.
25889207,"CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe."
28638221,Prevalence of &lt;i&gt;IFNL3&lt;/i&gt; rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C.
21254158,Quantitation of pretreatment serum interferon-γ-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response.
23080225,Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants.
18618621,SLC6A4 variation and citalopram response.
22006096,"Genomics of ADME gene expression: mapping expression quantitative trait loci relevant for absorption, distribution, metabolism and excretion of drugs in human liver."
28243137,Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6.
9689128,Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.
26039043,Effects of the CYP3A4*1B Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Adult Renal Transplant Recipients: A Meta-Analysis.
23646118,Effects of CYP2C19 loss-of-function variants on the eradication of H. pylori infection in patients treated with proton pump inhibitor-based triple therapy regimens: a meta-analysis of randomized clinical trials.
30914949,Association Study Among Candidate Genetic Polymorphisms and Chemotherapy-Related Severe Toxicity in Testicular Cancer Patients.
9653159,Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?
28112181,IL-3 and CTLA4 gene polymorphisms may influence the tacrolimus dose requirement in Chinese kidney transplant recipients.
19890249,The role of organic anion-transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics.
22407409,PharmGKB summary:  very important pharmacogene information for CYP3A5.
24816252,An atlas of genetic influences on human blood metabolites.
27997040,Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.
25916514,FASTKD2 and human memory: functional pathways and prospects for novel therapeutic target development for Alzheimer's disease and age-associated memory decline.
23682072,Characterization of raloxifene glucuronidation: potential role of UGT1A8 genotype on raloxifene metabolism in vivo.
25798582,Involvement of cytochrome P450 1A1 and glutathione S-transferase P1 polymorphisms and promoter hypermethylation in the progression of anti-tuberculosis drug-induced liver injury: a case-control study.
17439540,SLCO1B1 521T--&amp;gt;C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patients.
19371316,CYP2B6 (c.516G--&amp;gt;T) and CYP2A6 (*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients.
22954510,Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol.
26111151,PharmGKB summary: peginterferon-α pathway.
23665868,A meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokinetics.
29152138,The &lt;i&gt;hOCT1&lt;/i&gt; and &lt;i&gt;ABCB1&lt;/i&gt; polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia.
26699619,Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.
25844821,Lansoprazole Is Associated with Worsening Asthma Control in Children with the CYP2C19 Poor Metabolizer Phenotype.
16400613,A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency.
19936169,Drospirenone/ethinyl estradiol 3 mg/20 mug (24/4 day regimen): hormonal contraceptive choices - use of a fourth-generation progestin.
24220207,PharmGKB summary: mycophenolic acid pathway.
21441248,Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals.
26410689,Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.
22951632,Underlying genetic structure impacts the association between CYP2B6 polymorphisms and response to efavirenz and nevirapine.
19119263,G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.
27574448,Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel.
18281305,Impact of CYP2B6 983T&amp;gt;C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients.
20056557,Mu-opioid receptors are not necessary for nortriptyline treatment of neuropathic allodynia.
26801900,Pharmacogenetics driving personalized medicine: analysis of genetic polymorphisms related to breast cancer medications in Italian isolated populations.
22474613,HIV-1 antiretroviral drug therapy.
23859569,OCT1 genetic variants influence the pharmacokinetics of morphine in children.
26991336,The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children.
16179085,Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841].
25637052,Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma.
24729586,Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes.
26417955,Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing.
25611810,Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa.
21808284,Gender-stratified gene and gene-treatment interactions in smoking cessation.
26729753,Pharmacogenomic Genome-Wide Meta-Analysis of Blood Pressure Response to β-Blockers in Hypertensive African Americans.
23150149,NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapy.
27058899,eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study.
20981002,Breaking barriers in the genomics and pharmacogenetics of drug addiction.
17622941,Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants.
25147095,CYP2B6 c.983T&amp;gt;C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populations.
29755652,Correlation of MDR1 gene polymorphism with propofol combined with remifentanil anesthesia in pediatric tonsillectomy.
18509327,Pharmacogenetic pathway analysis of docetaxel elimination.
25461247,Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.
26265436,Serotonergic gene variation in substance use pharmacotherapy: a systematic review.
22094953,Associations of ABCB1 3435C&amp;gt;T and IL-10-1082G&amp;gt;A polymorphisms with long-term sirolimus dose requirements in renal transplant patients.
26463708,Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy.
21192344,CYP2C19 variation and citalopram response.
22108237,The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients.
22915658,Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group.
18539621,Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX.
23799528,Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies.
18285551,Association of common C-reactive protein (CRP) gene polymorphisms with baseline plasma CRP levels and fenofibrate response: the GOLDN study.
23065688,Glutathione S-transferase P1 single nucleotide polymorphism predicts permanent ototoxicity in children with medulloblastoma.
26877068,Race-Specific Influence of CYP4F2 on Dose and Risk of Hemorrhage Among Warfarin Users.
27385990,Prospective study of the UGT1A1*27 gene polymorphism during irinotecan therapy in patients with lung cancer: Results of Lung Oncology Group in Kyusyu (LOGIK1004B).
26186989,Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
21388237,Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.
24853734,Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metformin.
23166513,RHOA is a modulator of the cholesterol-lowering effects of statin.
21502584,Pharmacogenomics: the genetics of variable drug responses.
24892773,PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2.
20350125,"Pharmacogenomics of membrane transporters: past, present and future."
26307985,Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation.
28819312,Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles.
19074728,Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy.
18850169,"Coffee, CYP1A2 genotype and risk of myocardial infarction."
26730167,First-line eradication for Helicobacter pylori-positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype.
28605058,Cardiovascular Pharmacogenomics and Cognitive Function in Patients with Schizophrenia.
18241283,Effect of CYP2C19*2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians.
23119086,Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate.
16998491,A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC.
25148458,Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics.
17654295,Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation.
20876785,In vitro cytochrome P450-mediated metabolism of exemestane.
16355252,"Clines, clusters, and the effect of study design on the inference of human population structure."
15453913,Single nucleotide polymorphisms in the apolipoprotein B and low density lipoprotein receptor genes affect response to antihypertensive treatment.
18279474,Serotonin transporter polymorphism and bleeding time during SSRI therapy.
23856854,Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders.
18261733,"Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER."
23478884,Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?
25556837,"Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity."
19752398,"Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly."
22680342,Influence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV-positive patients using dried sample spot devices.
21178985,Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study.
29290749,Rasburicase-induced Hemolytic Anemia in an Adolescent With Unknown Glucose-6-Phosphate Dehydrogenase Deficiency.
23809542,The CYP2C19*17 variant is not independently associated with clopidogrel response.
28184434,Tell-Tale SNPs: The Role of CYP2B6 in Methadone Fatalities.
21851379,The effects of a single nucleotide polymorphism in SLCO1B1 on the pharmacodynamics of pravastatin.
25155933,Familial risk for alcohol dependence and developmental changes in BMI: the moderating influence of addiction and obesity genes.
27711230,The Role of Hepatitis C Virus Core Antigen Testing in the Era of Direct Acting Antiviral Therapies: What We Can Learn from the Protease Inhibitors.
22723959,Paraoxonase-1 is not a major determinant of stent thrombosis in a Taiwanese population.
26977927,A New Pharmacogenetic Algorithm to Predict the Most Appropriate Dosage of Acenocoumarol for Stable Anticoagulation in a Mixed Spanish Population.
27549341,Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer.
24071851,Emerging landscape of oncogenic signatures across human cancers.
26264253,Predictive factors for 24 weeks sustained virologic response (SVR24) and viral relapse in patients treated with simeprevir plus peginterferon and ribavirin.
22992668,Pharmacogenomics knowledge for personalized medicine.
27091191,A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study.
22547144,"The PPAR alpha gene is associated with triglyceride, low-density cholesterol and inflammation marker response to fenofibrate intervention: the GOLDN study."
23677058,Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia.
26227246,Susceptibility loci for heroin and cocaine addiction in the serotonergic and adrenergic pathways in populations of different ancestry.
20031551,Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response.
21546862,PharmGKB summary:  citalopram pharmacokinetics pathway.
19297219,Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy.
18574025,The largest prospective warfarin-treated cohort supports genetic forecasting.
25329996,Effects of cytochrome P450 2C19 and paraoxonase 1 polymorphisms on antiplatelet response to clopidogrel therapy in patients with coronary artery disease.
28302415,"A prospective study to assess the association between genotype, phenotype and Prakriti in individuals on phenytoin monotherapy."
20530282,Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.
22012471,"ADORA2A Gene variation, caffeine, and emotional processing: a multi-level interaction on startle reflex."
19676097,FKBP5 polymorphisms and antidepressant response in geriatric depression.
19996755,Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms.
28186161,Genetic variants in interferon-λ 4 influences HCV clearance in Chinese Han population.
19802338,"Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication."
24024897,RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients.
23252947,Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.
19779319,"CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patients."
23486447,Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.
22927450,A single-nucleotide polymorphism in CYP2B6 leads to &amp;gt;3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women.
26461463,Pharmacokinetics of metoprolol during pregnancy and lactation.
19671875,Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.
18547065,Machine learning methods and docking for predicting human pregnane X receptor activation.
27261829,Pharmacogenetics of Potassium Channel Blockers.
22130800,Vitamin K antagonists in children with heart disease: height and VKORC1 genotype are the main determinants of the warfarin dose requirement.
24126707,Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females.
19833260,The SLCO1B1*5 genetic variant is associated with statin-induced side effects.
24084768,Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects.
26267224,Dissecting ancestry genomic background in substance dependence genome-wide association studies.
23613831,"The KCNH2 genetic polymorphism (1956, C&amp;gt;T) is a novel biomarker that is associated with CCB and α,β-ADR blocker response in EH patients in China."
19659438,"CYP2B6 variants and plasma efavirenz concentrations during antiretroviral therapy in Port-au-Prince, Haiti."
25287681,Detection of allele specific differences in IFNL3 (IL28B) mRNA expression.
24658827,"The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients."
22566560,Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain.
23913015,PharmGKB summary: methylene blue pathway.
20679962,Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil.
23199531,Cytochrome P450-mediated drug metabolism in the brain.
21684175,"alcohol, smoking, and caffeine in relation to fecundability, with effect modification by NAT2."
28705252,"Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial."
26441325,ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection.
26536870,Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover.
26715213,"Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naïve HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study."
23973251,SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.
23233662,Genome-wide study of methotrexate clearance replicates SLCO1B1.
21358750,Nerve growth factor β polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment.
26911666,Integrative role of vitamin D related and Interleukin-28B genes polymorphism in predicting treatment outcomes of Chronic Hepatitis C.
20389299,Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism.
22092036,"Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes."
5365949,An improved and simplified method of detecting the acetylator phenotype.
21386754,"Cerivastatin, genetic variants, and the risk of rhabdomyolysis."
23874514,HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity.
24549002,Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients.
26164721,"Individual and Combined Associations of Genetic Variants in CYP3A4, CYP3A5, and SLCO1B1 With Simvastatin and Simvastatin Acid Plasma Concentrations."
17434923,Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2.
25988058,Tumor lysis syndrome and acute anemia in an African-American man with chronic lymphocytic leukemia.
22015451,A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome.
20179710,Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide.
15280927,UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer.
28525903,"Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia."
20452521,Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.
23788015,"PharmGKB summary: Diuretics pathway, pharmacodynamics."
28002639,Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron.
24616296,"Adoption of a clinical pharmacogenomics implementation program during outpatient care--initial results of the University of Chicago ""1,200 Patients Project""."
21281405,"Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease."
19034036,The beta2 adrenergic receptor Gln27Glu polymorphism affects insulin resistance in patients with heart failure: possible modulation by choice of beta blocker.
25171759,The MYLIP p.N342S polymorphism is associated with response to lipid-lowering therapy in Brazilian patients with familial hypercholesterolemia.
25869015,Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study.
15024131,Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant.
21689142,Pharmacokinetics and pharmacodynamics following maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variants.
23305245,Trimethoprim-metformin interaction and its genetic modulation by OCT2 and MATE1 transporters.
27217270,Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.
23133602,Pharmacogenetics of efficacy and safety of HCV treatment in HCV-HIV coinfected patients: significant associations with IL28B and SOCS3 gene variants.
24762860,"Cytochrome p450 gene variants, race, and mortality among clopidogrel-treated patients after acute myocardial infarction."
23942138,SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalink.
25001883,"Pharmacogenetics of warfarin in a paediatric population: time in therapeutic range, initial and stable dosing and adverse effects."
22094953,Associations of ABCB1 3435C&amp;gt;T and IL-10-1082G&amp;gt;A polymorphisms with long-term sirolimus dose requirements in renal transplant patients.
19297219,Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy.
21912424,CYP4A11 variant is associated with high-density lipoprotein cholesterol in women.
22328925,Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients.
27247849,Genetic variation and cognitive dysfunction in opioid-treated patients with cancer.
23942138,SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalink.
25367448,FTO rs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients.
19034036,The beta2 adrenergic receptor Gln27Glu polymorphism affects insulin resistance in patients with heart failure: possible modulation by choice of beta blocker.
28819312,Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles.
29668752,The CYP1A2 -163C&amp;gt;A polymorphism does not alter the effects of caffeine on basketball performance.
25798582,Involvement of cytochrome P450 1A1 and glutathione S-transferase P1 polymorphisms and promoter hypermethylation in the progression of anti-tuberculosis drug-induced liver injury: a case-control study.
17654295,Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation.
26670100,"Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study."
19802338,"Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication."
23150149,NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapy.
22951632,Underlying genetic structure impacts the association between CYP2B6 polymorphisms and response to efavirenz and nevirapine.
29705271,Effects of human SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of acetaminophen and opioid drugs by the cytosolic sulfotransferase SULT1A3.
25844821,Lansoprazole Is Associated with Worsening Asthma Control in Children with the CYP2C19 Poor Metabolizer Phenotype.
25148458,Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics.
27261829,Pharmacogenetics of Potassium Channel Blockers.
24107802,Hyperbilirubinemia in pazopanib- or sunitinib-treated patients in COMPARZ is associated with UGT1A1 polymorphisms.
23071495,"Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms."
18855529,Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following acute coronary syndromes.
18285551,Association of common C-reactive protein (CRP) gene polymorphisms with baseline plasma CRP levels and fenofibrate response: the GOLDN study.
26313268,"Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer."
24892773,PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2.
27217270,Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.
25461247,Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.
24729586,Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes.
18509327,Pharmacogenetic pathway analysis of docetaxel elimination.
24549002,Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients.
26265436,Serotonergic gene variation in substance use pharmacotherapy: a systematic review.
24101478,Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity.
20350125,"Pharmacogenomics of membrane transporters: past, present and future."
29152138,The &lt;i&gt;hOCT1&lt;/i&gt; and &lt;i&gt;ABCB1&lt;/i&gt; polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia.
26227246,Susceptibility loci for heroin and cocaine addiction in the serotonergic and adrenergic pathways in populations of different ancestry.
28186161,Genetic variants in interferon-λ 4 influences HCV clearance in Chinese Han population.
26729753,Pharmacogenomic Genome-Wide Meta-Analysis of Blood Pressure Response to β-Blockers in Hypertensive African Americans.
22915658,Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group.
16400613,A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency.
25869015,Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study.
24353446,"Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel response."
26461463,Pharmacokinetics of metoprolol during pregnancy and lactation.
18618621,SLC6A4 variation and citalopram response.
24220207,PharmGKB summary: mycophenolic acid pathway.
22765258,Population pharmacokinetics of unbound mycophenolic acid in adult allogeneic haematopoietic cell transplantation: effect of pharmacogenetic factors.
21546862,PharmGKB summary:  citalopram pharmacokinetics pathway.
27767376,Pharmacogenomics and histone deacetylase inhibitors.
19833260,The SLCO1B1*5 genetic variant is associated with statin-induced side effects.
21357676,Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption.
24024897,RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients.
26264253,Predictive factors for 24 weeks sustained virologic response (SVR24) and viral relapse in patients treated with simeprevir plus peginterferon and ribavirin.
15453913,Single nucleotide polymorphisms in the apolipoprotein B and low density lipoprotein receptor genes affect response to antihypertensive treatment.
22012471,"ADORA2A Gene variation, caffeine, and emotional processing: a multi-level interaction on startle reflex."
18261733,"Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER."
22015451,A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome.
24616296,"Adoption of a clinical pharmacogenomics implementation program during outpatient care--initial results of the University of Chicago ""1,200 Patients Project""."
22992668,Pharmacogenomics knowledge for personalized medicine.
26536870,Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover.
26410689,Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.
27966227,Tacrolimus dose requirements in paediatric renal allograft recipients are characterized by a biphasic course determined by age and bone maturation.
25556837,"Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity."
24658827,"The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients."
22293536,PharmGKB summary:  caffeine pathway.
20679962,Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil.
23132553,Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis.
20389299,Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism.
23856854,Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders.
26109805,β-2 Adrenergic receptor gene polymorphism and response to propranolol in cirrhosis.
24710841,Effectiveness of clopidogrel dose escalation to normalize active metabolite exposure and antiplatelet effects in CYP2C19 poor metabolizers.
23252947,Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.
22723959,Paraoxonase-1 is not a major determinant of stent thrombosis in a Taiwanese population.
23809542,The CYP2C19*17 variant is not independently associated with clopidogrel response.
28705252,"Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial."
24217698,Population pharmacokinetic and pharmacogenetic analysis of nevirapine in hypersensitive and tolerant HIV-infected patients from Malawi.
27574448,Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel.
19752398,"Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly."
17622941,Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants.
19890249,The role of organic anion-transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics.
16201835,A C1173T dimorphism in the VKORC1 gene determines coumarin sensitivity and bleeding risk.
27058899,eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study.
17439540,SLCO1B1 521T--&amp;gt;C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patients.
25889207,"CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe."
18322281,Genetic determinants of response to warfarin during initial anticoagulation.
23080225,Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants.
16998491,A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC.
23530079,An in vivo drug screening model using glucose-6-phosphate dehydrogenase deficient mice to predict the hemolytic toxicity of 8-aminoquinolines.
20530282,Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.
23486447,Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.
27549341,Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer.
23384627,Methacholine PC20 in African Americans and whites with asthma with homozygous genotypes at ADRB2 codon 16.
23788015,"PharmGKB summary: Diuretics pathway, pharmacodynamics."
26491254,A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis.
24019752,CYP2C19 polymorphisms in the Thai population and the clinical response to clopidogrel in patients with atherothrombotic-risk factors.
25171759,The MYLIP p.N342S polymorphism is associated with response to lipid-lowering therapy in Brazilian patients with familial hypercholesterolemia.
27711230,The Role of Hepatitis C Virus Core Antigen Testing in the Era of Direct Acting Antiviral Therapies: What We Can Learn from the Protease Inhibitors.
23665868,A meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokinetics.
20452521,Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.
27385990,Prospective study of the UGT1A1*27 gene polymorphism during irinotecan therapy in patients with lung cancer: Results of Lung Oncology Group in Kyusyu (LOGIK1004B).
28448657,Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer.
23874514,HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity.
30914949,Association Study Among Candidate Genetic Polymorphisms and Chemotherapy-Related Severe Toxicity in Testicular Cancer Patients.
23065688,Glutathione S-transferase P1 single nucleotide polymorphism predicts permanent ototoxicity in children with medulloblastoma.
25637052,Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma.
25069381,Mechanisms and assessment of statin-related muscular adverse effects.
23973251,SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.
25988058,Tumor lysis syndrome and acute anemia in an African-American man with chronic lymphocytic leukemia.
25329996,Effects of cytochrome P450 2C19 and paraoxonase 1 polymorphisms on antiplatelet response to clopidogrel therapy in patients with coronary artery disease.
28112181,IL-3 and CTLA4 gene polymorphisms may influence the tacrolimus dose requirement in Chinese kidney transplant recipients.
19019189,Common candidate gene variants are associated with QT interval duration in the general population.
19924111,"Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment."
23613831,"The KCNH2 genetic polymorphism (1956, C&amp;gt;T) is a novel biomarker that is associated with CCB and α,β-ADR blocker response in EH patients in China."
26977146,The Impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 Polymorphisms on Metformin Therapeutic Efficacy in Chinese Type 2 Diabetes Patients.
18241283,Effect of CYP2C19*2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians.
24816252,An atlas of genetic influences on human blood metabolites.
28184434,Tell-Tale SNPs: The Role of CYP2B6 in Methadone Fatalities.
18070221,"Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants."
20056557,Mu-opioid receptors are not necessary for nortriptyline treatment of neuropathic allodynia.
28525903,"Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia."
27859023,Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-Analysis.
29333880,Pharmacogenetic analysis of opioid dependence treatment dose and dropout rate.
16179085,Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841].
26699619,Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.
26911666,Integrative role of vitamin D related and Interleukin-28B genes polymorphism in predicting treatment outcomes of Chronic Hepatitis C.
26417955,Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing.
23646118,Effects of CYP2C19 loss-of-function variants on the eradication of H. pylori infection in patients treated with proton pump inhibitor-based triple therapy regimens: a meta-analysis of randomized clinical trials.
23166513,RHOA is a modulator of the cholesterol-lowering effects of statin.
26039043,Effects of the CYP3A4*1B Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Adult Renal Transplant Recipients: A Meta-Analysis.
23859569,OCT1 genetic variants influence the pharmacokinetics of morphine in children.
23677058,Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia.
20981002,Breaking barriers in the genomics and pharmacogenetics of drug addiction.
25155933,Familial risk for alcohol dependence and developmental changes in BMI: the moderating influence of addiction and obesity genes.
15280927,UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer.
21502584,Pharmacogenomics: the genetics of variable drug responses.
21689142,Pharmacokinetics and pharmacodynamics following maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variants.
16722833,Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes.
25545243,"Oxidative stress-related genetic polymorphisms are associated with the prognosis of metastatic gastric cancer patients treated with epirubicin, oxaliplatin and 5-fluorouracil combination chemotherapy."
19671875,Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.
26710337,A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial Fibrillation.
18279474,Serotonin transporter polymorphism and bleeding time during SSRI therapy.
25147095,CYP2B6 c.983T&amp;gt;C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populations.
28002639,Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron.
21851379,The effects of a single nucleotide polymorphism in SLCO1B1 on the pharmacodynamics of pravastatin.
23133602,Pharmacogenetics of efficacy and safety of HCV treatment in HCV-HIV coinfected patients: significant associations with IL28B and SOCS3 gene variants.
20179710,Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide.
19057464,Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.
26111151,PharmGKB summary: peginterferon-α pathway.
26186989,Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
22547144,"The PPAR alpha gene is associated with triglyceride, low-density cholesterol and inflammation marker response to fenofibrate intervention: the GOLDN study."
20048079,Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors.
23382909,Glucuronidation by UGT1A1 is the dominant pathway of the metabolic disposition of belinostat in liver cancer patients.
22680342,Influence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV-positive patients using dried sample spot devices.
29318894,Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients.
24126707,Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females.
20876785,In vitro cytochrome P450-mediated metabolism of exemestane.
22474613,HIV-1 antiretroviral drug therapy.
18574025,The largest prospective warfarin-treated cohort supports genetic forecasting.
16355252,"Clines, clusters, and the effect of study design on the inference of human population structure."
21386754,"Cerivastatin, genetic variants, and the risk of rhabdomyolysis."
25611810,Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa.
20031551,Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response.
23682072,Characterization of raloxifene glucuronidation: potential role of UGT1A8 genotype on raloxifene metabolism in vivo.
18850169,"Coffee, CYP1A2 genotype and risk of myocardial infarction."
28745549,Prior opioid exposure influences parents' sharing of their children's CYP2D6 research results.
26307985,Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation.
22407409,PharmGKB summary:  very important pharmacogene information for CYP3A5.
22307138,Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia.
23913015,PharmGKB summary: methylene blue pathway.
26977927,A New Pharmacogenetic Algorithm to Predict the Most Appropriate Dosage of Acenocoumarol for Stable Anticoagulation in a Mixed Spanish Population.
23305245,Trimethoprim-metformin interaction and its genetic modulation by OCT2 and MATE1 transporters.
23233662,Genome-wide study of methotrexate clearance replicates SLCO1B1.
21358750,Nerve growth factor β polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment.
22566560,Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain.
26730167,First-line eradication for Helicobacter pylori-positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype.
22927450,A single-nucleotide polymorphism in CYP2B6 leads to &amp;gt;3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women.
21178985,Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study.
19659438,"CYP2B6 variants and plasma efavirenz concentrations during antiretroviral therapy in Port-au-Prince, Haiti."
29844858,Genetic polymorphism of &lt;i&gt;SLC31A1&lt;/i&gt; is associated with clinical outcomes of platinum-based chemotherapy in non-small-cell lung cancer patients through modulating microRNA-mediated regulation.
28302415,"A prospective study to assess the association between genotype, phenotype and Prakriti in individuals on phenytoin monotherapy."
27524899,Long-term administration of escitalopram in patients with social anxiety disorder in Japan.
19512956,Antiestrogen pathway (aromatase inhibitor).
17485248,CoQ10 deficiency diseases in adults.
25916514,FASTKD2 and human memory: functional pathways and prospects for novel therapeutic target development for Alzheimer's disease and age-associated memory decline.
23199531,Cytochrome P450-mediated drug metabolism in the brain.
21254158,Quantitation of pretreatment serum interferon-γ-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response.
22954510,Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol.
19119263,G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.
23119086,Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate.
26715213,"Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naïve HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study."
19371316,CYP2B6 (c.516G--&amp;gt;T) and CYP2A6 (*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients.
26991336,The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children.
23612435,An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.
15024131,Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant.
26267224,Dissecting ancestry genomic background in substance dependence genome-wide association studies.
25287681,Detection of allele specific differences in IFNL3 (IL28B) mRNA expression.
22092036,"Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes."
23799528,Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies.
18547065,Machine learning methods and docking for predicting human pregnane X receptor activation.
21388237,Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.
19074728,Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy.
27997040,Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.
28261382,Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C.
25115783,Methaemoglobinaemia in a G6PD-deficient child treated with rasburicase.
26779253,An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients.
29755652,Correlation of MDR1 gene polymorphism with propofol combined with remifentanil anesthesia in pediatric tonsillectomy.
22006096,"Genomics of ADME gene expression: mapping expression quantitative trait loci relevant for absorption, distribution, metabolism and excretion of drugs in human liver."
26463708,Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy.
20130494,Association of common variants of CYP4A11 and CYP4F2 with stroke in the Han Chinese population.
20523342,IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population.
24071851,Emerging landscape of oncogenic signatures across human cancers.
26857349,Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network.
24084768,Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects.
28244812,Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing.
24853734,Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metformin.
17434923,Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2.
18838503,"Expression and functional analysis of CYP2D6.24, CYP2D6.26, CYP2D6.27, and CYP2D7 isozymes."
18281305,Impact of CYP2B6 983T&amp;gt;C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients.
28243137,Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6.
21808284,Gender-stratified gene and gene-treatment interactions in smoking cessation.
19779319,"CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patients."
29352482,Influence of pharmacogenetic polymorphisms and demographic variables on metformin pharmacokinetics in an admixed Brazilian cohort.
29737521,Age- and Genotype-Dependent Variability in the Protein Abundance and Activity of Six Major Uridine Diphosphate-Glucuronosyltransferases in Human Liver.
18539621,Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX.
21281405,"Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease."
26877068,Race-Specific Influence of CYP4F2 on Dose and Risk of Hemorrhage Among Warfarin Users.
22130800,Vitamin K antagonists in children with heart disease: height and VKORC1 genotype are the main determinants of the warfarin dose requirement.
21441248,Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals.
26801900,Pharmacogenetics driving personalized medicine: analysis of genetic polymorphisms related to breast cancer medications in Italian isolated populations.
30304062,KIF6 gene as a pharmacogenetic marker for lipid-lowering effect in statin treatment.
26164721,"Individual and Combined Associations of Genetic Variants in CYP3A4, CYP3A5, and SLCO1B1 With Simvastatin and Simvastatin Acid Plasma Concentrations."
21684175,"alcohol, smoking, and caffeine in relation to fecundability, with effect modification by NAT2."
24762860,"Cytochrome p450 gene variants, race, and mortality among clopidogrel-treated patients after acute myocardial infarction."
28638221,Prevalence of &lt;i&gt;IFNL3&lt;/i&gt; rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C.
26441325,ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection.
25974703,Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
23478884,Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?
22108237,The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients.
19056598,"Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states."
26637161,UGT1A1 genotype-dependent dose adjustment of belinostat in patients with advanced cancers using population pharmacokinetic modeling and simulation.
29290749,Rasburicase-induced Hemolytic Anemia in an Adolescent With Unknown Glucose-6-Phosphate Dehydrogenase Deficiency.
26880915,Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents.
19676097,FKBP5 polymorphisms and antidepressant response in geriatric depression.
28605058,Cardiovascular Pharmacogenomics and Cognitive Function in Patients with Schizophrenia.
27091191,A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study.
19996755,Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms.
25504915,Factors affecting time to maintenance dose in patients initiating warfarin.
27026620,Developing knowledge resources to support precision medicine: principles from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
21270786,CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.
24648345,Comparative functional analysis of DPYD variants of potential clinical relevance to dihydropyrimidine dehydrogenase activity.
27441996,Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
17302989,Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews.
23687529,Reformulation of controlled-release oxycodone and pharmacy dispensing patterns near the US-Canada border.
22166985,Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.
24885489,The use of global positional satellite location in dementia: a feasibility study for a randomised controlled trial.
21593296,Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function.
22877499,External validity in healthy public policy: application of the RE-AIM tool to the field of housing improvement.
23321218,Adherence to wearing prescription custom-made footwear in patients with diabetes at high risk for plantar foot ulceration.
23980939,"Utilization, benefits, and impact of an e-consultation service across diverse specialties and primary care providers."
24375570,A noninvasive handheld assistive device to accommodate essential tremor: a pilot study.
19480676,Can abuse deterrent formulations make a difference? Expectation and speculation.
26597979,"Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock."
22184555,The prevalence of chronic pain in Canada.
24800858,Monitoring of internet forums to evaluate reactions to the introduction of reformulated OxyContin to deter abuse.
27002113,Genetic manipulation for inherited neurodegenerative diseases: myth or reality?
24956937,Integration of existing systematic reviews into new reviews: identification of guidance needs.
19841152,Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria.
26092286,ROBIS: A new tool to assess risk of bias in systematic reviews was developed.
19133110,Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields).
26903338,The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).
18616818,Methods for the thematic synthesis of qualitative research in systematic reviews.
26576762,"Diagnostic imaging capabilities of the Ocelot -Optical Coherence Tomography System, ex-vivo evaluation and clinical relevance."
19366754,Ethical issues in stem cell research.
20925938,"A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation."
22000347,Global spread of Carbapenemase-producing Enterobacteriaceae.
27445618,Systematic Review of Multidisciplinary Chronic Pain Treatment Facilities.
20224959,Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head.
19969578,Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone.
15310807,Applying systematic review methods to studies of people's views: an example from public health research.
21655151,Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme.
23073726,"Abuse-deterrent formulations, an evolving technology against the abuse and misuse of opioid analgesics."
26080652,"Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4-week, randomized, placebo-controlled trial (EASE-1)."
23796131,Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.
26379095,Home Use of an Artificial Beta Cell in Type 1 Diabetes.
22517391,American Academy of Orthopaedic Surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty.
28483845,Guideline for opioid therapy and chronic noncancer pain.
14745323,Evidence-based compression: prevention of stasis and deep vein thrombosis.
20404977,Estimating the national wage loss from cancer in Canada.
23571362,Decontamination of targeted pathogens from patient rooms using an automated ultraviolet-C-emitting device.
26681725,Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study.
21067804,"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials."
23469984,Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry.
18624666,Impact of an environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms.
25105438,Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada.
25077124,Geographic and facility-level variation in the use of peritoneal dialysis in Canada: a cohort study.
24734111,How to assess the external validity and model validity of therapeutic trials: a conceptual approach to systematic review methodology.
25608648,Economic burden of illness associated with diabetic foot ulcers in Canada.
19136486,"Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial."
24842558,Efficacy and safety of alirocumab in patients with heterozygous familial hypercholesterolemia not adequately controlled with current lipid-lowering therapy: design and rationale of the ODYSSEY FH studies.
26622099,Treatment of Chronic Total Occlusions Using the Avinger Ocelot Crossing Catheter.
23952603,Patients' and clinicians' experiences and perceptions of the primary care management of insomnia: qualitative study.
24838219,"Human Growth Hormone Delivery with a Microneedle Transdermal System: Preclinical Formulation, Stability, Delivery and PK of Therapeutically Relevant Doses."
25019442,Imaging across the life span: innovations in imaging and therapy for gynecologic cancer.
22759353,Using pathology-specific laboratory profiles in clinical pathology to reduce inappropriate test requesting: two completed audit cycles.
29661822,"Chronic pain associations struggle to raise awareness of ""silent epidemic""."
26203234,Multidisciplinary approach to the diagnosis and management of patients with peripheral arterial disease.
27853629,Current progress of human trials using stem cell therapy as a treatment for diabetes mellitus.
20423574,Patients' and clinicians' experiences of consultations in primary care for sleep problems and insomnia: a focus group study.
19377359,Management of MRI wait lists in Canada.
25780609,Cost analysis of in-centre nocturnal compared with conventional hemodialysis.
19187889,Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.
25687353,Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial.
23820147,Vertical ground reaction force-based analysis of powered exoskeleton-assisted walking in persons with motor-complete paraplegia.
23469038,Socioeconomic and geographic patterning of smoking behaviour in Canada: a cross-sectional multilevel analysis.
24231665,Economic evaluation of frequent home nocturnal hemodialysis based on a randomized controlled trial.
23546564,Discontinuation of statins in routine care settings: a cohort study.
26495208,Evaluation of AirXpanders for Breast Reconstruction: Early Experience from Sydney.
17583176,"Foot ulcers in the diabetic patient, prevention and treatment."
28320337,Barriers and facilitators to use of non-pharmacological treatments in chronic pain.
24635773,A randomized trial of protocol-based care for early septic shock.
26784127,"Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities."
21499581,The need for a Canadian pain strategy.
19148341,Peripheral arterial disease: lack of awareness in Canada.
22379382,Minimum equipment guidelines for paediatric prehospital care.
19622552,The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
18625828,Bisphosphonate-associated osteonecrosis of the jaw.
24672251,Cost-effectiveness analysis of orbital atherectomy plus balloon angioplasty vs balloon angioplasty alone in subjects with calcified femoropopliteal lesions.
28095138,"Leber congenital amaurosis, from darkness to light: An ode to Irene Maumenee."
19808924,Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes.
25114623,Breast reconstruction following prophylactic or therapeutic mastectomy for breast cancer: Recommendations from an evidence-based provincial guideline.
28669112,Adeno-Associated Virus (AAV) as a Vector for Gene Therapy.
23341635,Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement.
26171659,The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System.
27973601,High-Dose Opioid Prescribing and Opioid-Related Hospitalization: A Population-Based Study.
15684117,Economic evaluation of sirolimus-eluting stents.
21059726,Population based screening for chronic kidney disease: cost effectiveness study.
25160945,Ivabradine treatment in a chronic heart failure patient cohort: symptom reduction and improvement in quality of life in clinical practice.
21330217,"A review of the experience, epidemiology, and management of pain among American Indian, Alaska Native, and Aboriginal Canadian peoples."
23316699,A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusers.
24144604,Surgical management of hip osteoarthritis.
25523497,A survey of stakeholder perspectives on exoskeleton technology.
24916486,Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulation.
16855129,Preference-Based EQ-5D index scores for chronic conditions in the United States.
24260139,The landscape of inappropriate laboratory testing: a 15-year meta-analysis.
26730266,An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II): The TASC Steering Comittee(.).
22607822,The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
11114276,Bone scintigraphy for osteonecrosis of the knee in patients with non-traumatic osteonecrosis of the femoral head: comparison with magnetic resonance imaging.
23384329,A passive positioning alarm used by persons with dementia and their spouses--a qualitative intervention study.
22065359,Breast reconstruction after mastectomy for breast cancer.
14610281,Cancer risks attributable to low doses of ionizing radiation: assessing what we really know.
28276512,The efficacy and safety of SGLT2 inhibitors for adjunctive treatment of type 1 diabetes: a systematic review and meta-analysis.
23566021,"""Reducing unnecessary testing in a CPOE system through implementation of a targeted CDS intervention""."
23900563,Update on prescription extended-release opioids and appropriate patient selection.
24123484,Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics.
25269777,Efficacy and safety of alirocumab as add-on therapy in high-cardiovascular-risk patients with hypercholesterolemia not adequately controlled with atorvastatin (20 or 40 mg) or rosuvastatin (10 or 20 mg): design and rationale of the ODYSSEY OPTIONS Studies.
25565904,Atherectomy devices: technology update.
22876107,A review of abuse-deterrent opioids for chronic nonmalignant pain.
23166446,Lifestyle-oriented non-pharmacological treatments for fibromyalgia: a clinical overview and applications with home-based technologies.
21193661,Metallic copper as an antimicrobial surface.
22553242,Sustained reduction of microbial burden on common hospital surfaces through introduction of copper.
26174216,New Developments in the Psychological Management of Chronic Pain.
25041316,The burden of premature opioid-related mortality.
24747791,Controlling methicillin-resistant Staphylococcus aureus (MRSA) in a hospital and the role of hydrogen peroxide decontamination: an interrupted time series analysis.
24627370,Imaging appropriateness criteria: why Canadian family physicians should care.
24760263,Prevention of recurrent foot ulcers with plantar pressure-based in-shoe orthoses: the CareFUL prevention multicenter randomized controlled trial.
28541139,Factory-Calibrated Continuous Glucose Sensors: The Science Behind the Technology.
24791197,Offering assisted peritoneal dialysis is a cost-effective alternative to the current care pathway in frail elderly Dutch patients.
28718815,Regional Delivery of Chimeric Antigen Receptor (CAR) T-Cells for Cancer Therapy.
22315265,"Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines."
19325482,The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation.
23211265,Integrating online communities and social networks with computerised treatment for insomnia: a qualitative study.
24476213,Screen or not to screen for peripheral arterial disease: guidance from a decision model.
